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Abstract 
Collagen VI is a major protein of the extracellular matrix with a broad distribution in 
many tissues, including skeletal muscle and connective tissues. It is composed of three 
distinct alpha chains, α1, α2 and α3(VI), encoded by separate genes. Mutations of collagen 
VI genes in humans cause several muscle diseases, such as Bethlem myopathy and Ullrich 
congenital muscular dystrophy. Collagen VI null (Col6a1–/–) mice display a myopathic 
phenotype characterized by mitochondrial dysfunction, spontaneous apoptosis and 
autophagic impairments in myofibers. These findings indicate that collagen VI has a key 
role for skeletal muscle homeostasis.  
Before starting my PhD, I participated to a project aimed at investigating the effects of 
physical exercise on wild type and Col6a1–/– skeletal muscle. This work demonstrated for 
the first time that exercise is able to activate the autophagic response in muscle. 
Moreover, this study revealed that physical exercise is detrimental for Col6a1–/– muscles.  
I decided to focus my main PhD work on investigating the role of collagen VI in 
fibroblasts, which are the major cell type responsible for the secretion and extracellular 
deposition of this protein, and elucidating the consequences on fibroblasts due to ablation 
of collagen VI. In patients affected by Bethlem myopathy and Ullrich congenital muscular 
dystrophy, the mutated forms of collagen VI are produced and retained by fibroblasts, 
suggesting a potential contribution for this cell type in the onset and progression of 
muscle defects.  
To assess how lack of collagen VI impacts on fibroblast functions, I generated stable 
mouse embryonic fibroblast (MEF) lines from wild type and Col6a1–/– mice and showed 
that collagen VI is necessary for autophagy regulation and has prosurvival properties in 
fibroblasts. Col6a1–/– MEFs displayed accumulation of LC3 both basally and following 
autophagy induction. To dissect the autophagic response of these cells, I studied the 
autophagy flux and the activity of the nutrient sensor kinase mTOR. I found that in Col6a1–
/– MEFs the mTORC1 downstream targets, such as 4E-BP1 and S6, are persistently 
activated under nutrient depletion stimuli, leading to autophagy inhibition in starving 
  
II 
activation of the AMP-activated protein kinase. These signaling defects lead to massive 
accumulation of autophagosomes inside Col6a1–/– fibroblasts, due to a compromised 
autophagosome-lysosome fusion in association with the presence of enlarged lysosomes 
and LAMP-2 protein depletion. These lysosomal defects are also associated with aberrant 
localization and activity of TFEB, a master transcription factor for lysosome biogenesis 
and autophagy regulation.  
In addition, Col6a1–/– MEFs showed increased susceptibility to cell death, especially 
under nutrient stress, that ended with activation of the intrinsic pathway of apoptosis. 
This phenotype was specifically rescued by culturing cells onto purified collagen VI 
provided as an adhesive substrate. Lack of collagen VI also influenced the organization of 
the mitochondrial network, which has a key role in cell survival. Mitochondria of Col6a1–/– 
MEFs exhibited increased fragmented morphology, associated with Parkin translocation 
and defective mitophagy. 
These findings show that fibroblasts play a relevant role in the development of the 
pathophysiological defects of collagen VI null mice, a finding that provide a thus far 
undisclosed and valuable information for the diagnosis and therapy of inherited diseases 
associated with collagen VI gene mutations.  Moreover, they reveal for the first time a 
direct effect of collagen VI on the regulation of autophagy and associated mechanisms in 
this cell type. 
  III 
Riassunto 
Il collagene VI è una proteina della matrice extracellulare con caratteristiche uniche, 
presente ed abbondante in numerosi tessuti, come nel muscolo scheletrico e i tessuti 
connettivi. Si compone di tre diverse catene, chiamate α1, α2 e α3(VI), codificate da geni 
distinti. Mutazioni a carico dei geni per il collagene VI nell’uomo sono causa di diverse 
patologie muscolari, quali la miopatia di Bethlem e la distrofia muscolare congenita di 
Ullrich. Il modello murino privo di collagene VI (Col6a1–/–), generato nel nostro 
laboratorio, sviluppa un fenotipo miopatico caratterizzato da disfunzione mitocondriale, 
insorgenza di apoptosi e difetti di autofagia nelle miofibre muscolari. Il collagene VI risulta 
in sostanza fondamentale per l'omeostasi generale del muscolo scheletrico. 
Al termine della laurea specialistica, ho partecipato ad un primo progetto volto a 
studiare gli effetti dell'esercizio fisico sul muscolo scheletrico di topi wild type e Col6a1–/–. 
Questo lavoro ha dimostrato per la prima volta che l'esercizio fisico è in grado di attivare 
l'autofagia nel muscolo; in secondo luogo che l'esercizio fisico è dannoso per il muscolo 
dei topi Col6a1–/–, già soggetti a problemi di attivazione dell'autofagia, escludendone un 
possibile utilizzo come strategia terapeutica. 
In seguito ho deciso di focalizzare il mio lavoro di dottorato sullo studio delle 
alterazioni insorgenti in fibroblasti privi di collagene VI e sugli effetti diretti di questa 
proteina sulla regolazione dell'autofagia. Il fibroblasto è il principale tipo cellulare che 
produce collagene VI. Inoltre, in pazienti distrofici con patologie correlate a mutazioni del 
collagene VI, le varianti mutate di collagene VI vengono prodotte proprio dai fibroblasti e 
ritenute all'interno del loro citoplasma, suggerendo così un contributo primario dei 
fibroblasti nella patogenesi muscolare.  
Per indagare più a fondo il contributo di queste cellule, ho generato delle linee 
cellulari di fibroblasti embrionali murini (MEF) da topi wild type e Col6a1–/– e ho 
dimostrato come il collagene VI sia necessario per una corretta attivazione di autofagia e 
per la sopravvivenza dei fibroblasti. Per analizzare la risposta autofagica di queste cellule, 
ho studiato il flusso autofagico e l'attività della protein chinasi mTOR, uno dei principali 
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sensori cellulari di risposta ai nutrienti. Nei MEF Col6a1–/–, i target a valle di mTORC1, 4E-
BP1 ed S6, risultano costantemente attivati anche in seguito a stimoli di induzione di 
autofagia, ad indicare un'inibizione a valle della via autofagica. Tuttavia, nei MEF Col6a1–/– 
è presente uno squilibrio energetico generale, che porta all'iper-attivazione della protein 
chinasi attivata da AMP (AMPK), che a sua volta è implicata nell'induzione di autofagia. Le 
analisi relative al fattore di trascrizione TFEB, che svolge un ruolo chiave nella biogenesi e 
funzionalità lisosomiale, dimostrano inoltre un'alterata localizzazione e attività di questo 
fattore, ad indicare un'alterata risposta trascrizionale del programma autofagico dei 
fibroblasti Col6a1–/–. Questa complessa situazione porta infine ad un accumulo 
intracellulare di autofagosomi nei MEF Col6a1–/–, dovuto alla mancata fusione di 
autofagosomi e lisosomi, ed è inoltre associato alla presenza di lisosomi dilatati ed alla 
diminuzione dei livelli proteici di LAMP-2.  
Inoltre i MEF Col6a1–/– hanno dimostrato una maggiore suscettibilità a morte 
cellulare indotta da stress o induzione di autofagia, tramite attivazione della via intrinseca 
di apoptosi. È importante evidenziare che questo difetto viene specificatamente 
recuperato quando i fibroblasti sono coltivati su collagene VI purificato, fornito come 
substrato. L’assenza del collagene VI nei MEF Col6a1–/– influenza infine l'organizzazione 
della rete mitocondriale, la quale è nota svolgere un ruolo chiave nella sopravvivenza 
cellulare. I mitocondri dei MEF Col6a1–/– risultano infatti più frequentemente frammentati 
rispetto ai wild type, e questa alterazione potrebbe facilmente essere correlata ad una 
disfunzione mitocondriale. In questo contesto, i mitocondri Col6a1–/– inducono la  
traslocazione di Parkin e vengono sottoposti ad un'alterata risposta del processo selettivo 
di mitofagia. 
In conclusione, questi risultati dimostrano per la prima volta che i fibroblasti 
contribuiscono in modo rilevante all’insorgenza e alla progressione dei difetti 
patofisiologici nei topi Col6a1–/–, fornendo così informazioni preziose e finora ignote per 
la diagnosi e la terapia delle patologie legate a mutazioni nei geni codificanti per il 
collagene VI. Inoltre, essi dimostrano che il collagene VI svolge un effetto diretto sulla 
regolazione dell’autofagia e sui meccanismi ad essa associati in questo tipo cellulare. 
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Part I Introduction 
Part I: main project 
1. Introduction 
1.1. Extracellular matrix 
The extracellular matrix (ECM) is the dynamic and multifaceted space in which cells 
are layered and anchored to form specialized tissues and organs. This microenvironment 
plays a crucial role for tissue homeostasis and ensures proper functionality through 
physical cell-matrix interactions and structural support. Moreover, ECM proteins are 
involved in several key cellular processes such as binding, activation and presentation of 
soluble factors, modulation of morphogen gradients, maintenance of the stem cell niche, 
and signal transduction into cells (Hynes, 2009; Tsang, Cheung, Chan, and Cheah, 2010; 
Gattazzo, Urciuolo, and Bonaldo, 2014). 
The ECM displays a fine tissue-specific composition, but in general terms it is 
composed by major groups of secreted macromolecules. Mechanical strength and 
flexibility are allowed by fibrous proteins (typically collagens, fibronectin, elastin, and 
fibrillins). ECM components also include enzymes able to modify these molecules ,such as 
lysyl oxidase, and proteinases, such as the matrix metalloproteinases. Proteoglycans 
consist of different core proteins covalently linked to sulfated glycosaminoglycan side 
chains. These macromolecular complexes are important to assure the ECM hydration, thus 
providing tissue turgidity and facilitating molecular transport. Another category of 
molecules is able to connect cells to matrix and to modulate interactions with plasma 
membrane receptors. These are termed matricellular proteins or multifunctional adhesive 
proteins, such as thrombospondins and tenascins (Tsang et al., 2010; Hubmacher and 
Apte, 2013). 
Among ECM proteins, collagens are the most abundant components of connective 
tissues, mainly produced by fibroblasts. There are different subgroups of collagen types 
that differ to their structure and functions: fibril-forming collagens (such as types I, II, III, 
V), fibril-associated collagens with interrupted triple helix (such as types IX, XII, XIV), 
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beaded microfilaments (collagen type VI), multiplexin (such as types VII, XV and XVIII) 
and network-forming collagens (types IV, typical of the basement membrane, VI, VIII, and 
X) (Ricard-Blum, 2011). They are made of three polypeptide α chains that are enriched in 
regions with a repeated Gly-X-Y pattern, which is also known as the collage domain. The α 
chains assemble in homo- or hetero-trimeric fashions to form triple helical structures 
(Ricard-Blum, 2011; Brodsky and Persikov, 2005).  
ECM protein networking has a crucial role in modulate cell behavior and homeostasis. 
In parallel, different ECM defects have been linked to an increasing number of human 
pathologies, such as inflammation processes, muscle and neurodegenerative diseases 
(Tsang et al., 2010; Hubmacher and Apte, 2013). Mutant and knockout animal models for 
ECM molecules provide a valuable tool for translational studies and for the mechanistic 
understanding of human disease pathogenesis associated with ECM defects. 
 
1.2. Collagen VI 
Collagen VI is a protein with a broad and dynamic distribution in the ECM of several 
tissues, such as skeletal muscle, tendons, intervertebral disks, peripheral nerves, lungs, 
heart, adipose tissue, skin and cartilages (Kuo et al., 1997). Collagen VI is encoded by three 
different genes and is tipically composed of the three distinct polypeptides, called α1(VI) 
(140 kDa), α2(VI) (130 kDa) and α3(VI) (250-350 kDa) chains (Colombatti and Bonaldo, 
1987; Colombatti et al., 1995).   
The α1 and α2(VI) chains are encoded by Col6a1 and Col6a2 genes, mapping to 
chromosome 21q22.39, while α3(VI) is encoded by Col6a3, that is located on 2q37 
chromosome (Lampe and Bushby, 2005). The three α chains contain a triple helical 
domain of 335-336 amino acids, flanked by large N- and C-terminal globular regions made 
of repeated modules of about 200 amino acid residues sharing similarity with the von 
Willebrand factor type A (vWF-A)-like domain. The α1 and α2(VI) polypeptides contain 
one N-terminal- and two C-terminal vWF-A globular domains (namely N1, C1 and C2). The 
α3(VI) chain displays ten N-terminal and two C-terminal vWF-A domains (N1-N10 and 
C1-C2), followed by three additional C-terminal modules (C3-C5): a proline-rich domain, a 
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fibronectin type III domain and a Kunitz-like domain (Bonaldo et al., 1990) (Fig. 1). Col6a3 
transcripts can undergo multiple alternative splicing, therefore generating different 
α3(VI) variants characterized by a variable number of vWF-A modules (Saitta et al., 1990; 
Doliana et al., 1998). 
Collagen VI biosynthesis is a complex process involving multiple steps. Following 
translation and entry of the three α(VI) chains within the endoplasmic reticulum, the 
three chains associate in equimolar ratios giving rise to a triple helical monomer (≈500 
kDa), stabilized by disulfide bonds. Before secretion, monomers associate into disulfide-
bonded antiparallel dimers (=1,0000 kDa), which align to form tetramers (≈2,000 kDa) 
that are finally secreted in the extracellular space. Outside the cell, collagen VI tetramers 
associate laterally by non-covalent bonds, forming a network of beaded microfilaments in 
the ECM meshwork (Bernardi and Bonaldo, 2008).  
Collagen VI structure and networking not only favour cell embedding in the 
connective tissue. Thanks to its modularity, collagen VI is able to bind different 
components of the ECM and is involved in intracellular signaling. It was shown that 
collagen VI binds collagen IV and decorin at the basal lamina, creating a physical 
connection between muscle cells and ECM (Kuo et al., 1997). Furthermore, it can bind 
collagen I, collagen II, fibronectin, decorin and other ECM components (Bonaldo et al., 
1990; Sabatelli et al., 2001; Neill et al., 2012). Integrin α1β1 and α2β1 and the CSPG4/NG2 
proteoglycan are known membrane receptors able to bind collagen VI and transduce 
intracellular signals by acting on the cytoskeleton (Burg et al., 1996; Stallcup, 2002).  
Figure 1. Schematic structure of collagen VI. The alpha chains, α(VI), are divided into domains. N1-
N10, N-terminal vWF-A globular domains; C1-C5, C-terminal vWF-A globular domains; TH, triple helix. 
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Several mutations of human COL6 genes were reported, and they are mainly linked to 
inherited muscular disorders, indicating a critical role of this protein for skeletal muscle 
maintenance. Indeed, Bethlem myopathy (BM), Ullrich congenital muscular dystrophy 
(UCMD) and myosclerosis myopathy were found to be caused by mutations of collagen VI 
genes (Lampe and Bushby, 2005; Bönnemann, 2011). BM is characterized by axial and 
proximal muscle wasting and weakness, associated with finger flexion contractures. BM is 
usually mild, with slow progression of the symptoms (Pepe et al., 2002; Lampe and 
Bushby, 2005). The more severe UCMD is characterized by an early-onset muscle 
weakness and wasting, generalized and rapidly progressive, with proximal limb 
contractures, distal hyperlaxity, rigid spine and rare ability to walk. The rapid progression 
of UCMD clinical symptoms usually leads to early death, due to respiratory failure 
(Mercuri and Longman, 2005; Brinas et al., 2010). The third phenotype, myosclerosis 
myopathy, displays early and diffuse contractures resulting in severe limitation of 
movement of axial, proximal, and distal joints, and in a “woody” consistence of muscles 
(Merlini et al., 2008). 
 
1.2.1. Collagen VI null mouse model 
Several years ago, a collagen VI knockout mouse model (Col6a1–/–) was produced by 
targeted inactivation of Col6a1 gene. Despite the fact that α2(VI) and α3(VI) chains are 
normally translated, lack of the α1(VI) chain completely abolishes the assembly and 
secretion of collagen VI in the homozygous Col6a1–/– mice (Bonaldo et al., 1998). Thus, the 
Col6a1 null mice is a good model to investigate the function of collagen VI in vivo.  
Although Col6a1–/– mice undergo normal development, are fertile and do not display 
any obvious anatomical alteration, they are affected by an early onset myopathic disease 
with myofiber defects and muscle weakness (Bonaldo et al., 1998; Irwin et al., 2003). At 
the histological level, muscles of Col6a1–/– mice show an increased occurrence of centrally 
nucleated and degenerating myofibers, with variability in myofiber cross-sectional areas. 
Ultrastructural analysis revealed the occurrence of abnormal mitochondria and dilated 
sarcoplasmic reticulum cisternae in Col6a1–/–muscles. Moreover, TUNEL analyses 
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revealed a markedly increased incidence of apoptosis in Col6a1–/– muscles. Ex vivo studies 
show the presence of a latent mitochondrial dysfunction that impinges on Col6a1–/– 
myofiber functionality (Irwin et al., 2003). Mechanistic studies revealed an increased 
opening propensity of the permeability transition pore (PTP) of the inner mitochondrial 
membrane, thus leading to mitochondria depolarization and finally to apoptosis (Bernardi 
and Bonaldo, 2008). In vivo treatment with cyclosporin A, an inhibitor of the cyclophilin D 
that desensitizes PTP opening, was successful to rescue the apoptotic and mitochondrial 
defects and more importantly the myopathic phenotype of Col6a1–/– muscles. 
Independent studies in muscle biopsies and muscle cell cultures from BM and UCMD 
patients allowed to reveal the same pathomolecular defects in human collagen VI 
myopathies. As for Col6a1–/– mice, the latent mitochondrial dysfunction and spontaneous 
apoptosis of patients’ muscle cultures were rescued by cyclosporin A treatment, as well as 
by adhesion onto native collagen VI as a substrate (Angelin et al., 2007).  
In 2010, further mechanistic studies allowed to demonstrate that lack of collagen VI 
leads to a failure of autophagy in skeletal myofibers (Grumati et al., 2010). It was shown 
that Col6a1–/– muscles have a block of the autophagic flux, due to defective regulation of 
Beclin 1 and Bnip3, two key factors needed for activation of the autophagic process. 
Autophagosome formation is strongly reduced in muscles of Col6a1–/– mice , and they do 
not display activation of autophagy following 24-hour starvation, a well-known stimulus 
for induction of autophagy. As a consequence, Col6a1–/– muscles undergo a detrimental 
buildup of dysfunctional and damaged organelles. Interestingly, forced reactivation of 
autophagy in Col6a1–/– mice by genetic, pharmacological or nutritional means was 
successful in rescuing the myopathic phenotype and restoring muscle homeostasis and 
strength. The treatments to forcibly induce autophagy consisted of i) prolonged starvation 
(30-hour long) to study acute, short-term response; ii) feeding with a specifically designed 
chow with a lower protein content (“low-protein diet”) for one month; iii) rapamycin 
administration for 15 days; and iv) in vivo transfection of tibialis anterior muscles with a 
Beclin 1 cDNA construct (Grumati et al., 2010). Notably, these different approaches not 
only successfully reactivated autophagy in Col6a1–/– muscles, but also rescued the 
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apoptotic phenotype and ameliorated muscle histology and myofiber defects, leading also 
to recovery of functional properties with a significant increase of muscle strength in the 
low-protein diet approach.  
Much interestingly, the same study also demonstrated that Beclin 1 and Bnip3 protein 
levels are reduced in muscle biopsies from BM and UCMD patients, thus revealing that 
defective regulation of autophagy is a shared feature of mice and men with collagen VI 
deficiency (Grumati et al., 2010). Based on these findings, a pilot clinical trial with a 
nutritional approach and aimed at at restoring muscle autophagy was recently carried out in 
BM and UCMD patients (ClinicalTrials.gov Identifier NCT01438788; 
https://clinicaltrials.gov/ct2/show/NCT01438788). Towards this aim,  seven patients 
affected by collagen VI deficiency underwent a voluntary 1 year-long low-protein diet 
with a normocaloric daily food intake (Merlini and Nishino, 2014). During the last part of 
my PhD I participated to this study, evaluating the autophagic response to this nutritional 
protocol by biochemical studies in protein extracts prepared from muscle biopsies of the 
different patients, obtained before and at the end of the 1-year trial. The results of this 
trail indicate a positive regulation of autophagy in muscles of enrolled patients, which is 
remarkably associated with a reduced progression of clinical symptoms and muscle 
pathology (Merlini et al., manuscript in preparation). 
Interestingly, a subsequent study, in which I was involved during my post-graduate 
research experience, was aimed at evaluating whether physical exercise may exert a 
beneficial effect in Col6a1–/– mice, with an obvious relevance for the treatment of human 
collagen VI-related myopathies. Physical training was not able to induce autophagy in 
Col6a1–/– muscles, but instead had detrimental effects leading to exacerbation of the 
muscle defects due to accumulation of damaged proteins and dysfunctional organelles 
(Grumati et al., 2011). Of note, this work demonstrated for the first time that physical 
exercise is able to activate autophagy in skeletal muscles (Grumati et al., 2011; Nair and 
Klionsky, 2011).  
Although the phenotype of patients with collagen VI deficiencies and of Col6a1–/– mice 
clearly underline the critical role of this ECM component in skeletal muscles, as discussed 
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above collagen VI has a broad distribution in the body and likely exerts multiple functions 
in different tissues. Indeed, recent studies in Col6a1–/– mice also demonstrated a role for 
collagen VI in regulating in vivo Schwann cell differentiation, a function that is required for 
the proper maintenance of peripheral nerve myelination and function (Chen et al., 2014a). 
In addition, further studies in Col6a1–/– mice revealed that collagen VI acts on macrophage 
recruitment and polarization, promoting nerve regeneration after injury (Chen et al., 
2014b). 
Although all these studies point at collagen VI as a key ECM molecule exerting several 
important functions in different tissues, surprisingly very few literature works 
investigated the role of collagen VI in fibroblasts, i.e. the major cell type that primarily 
produces and secrete this ECM molecule in the different tissues including skeletal muscles 
(Hatamochi et al., 1989; Braghetta et al., 2008; Zou et al., 2008). Given the peculiar 
pathway of intracellular assembly of this ECM molecule and the strict requirement of the 
synthesis and association of the three α1(VI), α2(VI) and 3(VI) chains in equimolar ratios 
for the proper assembly, secretion and ECM deposition of collagen VI, it can be assumed 
that mutation or ablation of a single chain, as it occurs in Col6a1 null mice and in patients 
with dominant and recessive COL6A1-A3 mutations, may have detrimental effects for 
fibroblasts. Initial studies in fibroblasts cultures derived from Col6a1–/– mice confirmed 
that lack of α1(VI) chain completely abolish the assembly and secretion of collagen VI by 
these cells. Interestingly, Col6a2 and Col6a3 genes are normally transcribed in Col6a1–/– 
mice, but in the absence of α1(VI) the other two chains cannot be assembled and are 
retained within fibroblasts (Bonaldo et al., 1998). Studies in UCMD and BM patients 
confirmed that retention of collagen VI chains takes place in fibroblasts rather than 
myofibers or myoblasts, suggesting that fibroblasts themselves, responsible for the 
secretion of collagen VI, contribute significantly to the pathogenesis of UCMD and BM (Pan 
et al., 2003; Zou et al., 2008). It is therefore of great interest to elucidate how lack of 
collagen VI impacts on the homeostasis, survival and activity of fibroblasts. The major aim 
of my PhD project was to investigate whether collagen VI has an instructive role towards 
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Figure 2. Schematic representation of the different
fibroblast survival and autophagy and how lack of this ECM molecule affects fibroblast 
homeostasis.  
 
1.3. Autophagy in mammalian cells
The autophagy-lysosome system is one of the major catabolic pathways of the cell. 
Based on their functions and mechanisms, different types of autophagy were described: 
microautophagy, chaperone-mediated autophagy and macroautophagy (Fig. 2). 
Microautophagy leads to the engulfment and degradation of small amounts of cytoplasm 
by the lysosomal membrane itself. Chaperone
unfolded soluble proteins for degradation, through direct translocation across the 
lysosome membrane by the chaperone hsc70 and the lysosomal receptor LAMP
(lysosome-associated membrane protein type 
formation of unique double-membrane vesic
lived proteins, damaged organelles and pathogens, dispatching them to lysosomes for 
degradation and recycling, also in a selective manner (Mizushima 
2013). Macroautophagy (hereafter re
this discussion.  
 types of autophagy (Wirawan et al., 2012
 
-mediated autophagy (CMA) targets 
2A). Macroautophagy involves the 
les (called autophagosomes) that engulf long
et al., 2008; Boya 
ferred to as autophagy) will be of main interest for 
). 
-2A 
-
et al., 
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Autophagy is finely regulated by extracellular and intracellular nutrient and growth 
factor sensing via a complex pool of receptors and interactors (Feng et al., 2014; Stolz et 
al., 2014), which are strictly required for the adaptive response of the cell and for global 
tissue homeostasis. Autophagy usually acts as a cytoprotective mechanism. However the 
precise regulation of autophagy is even more crucial, so that both excessive and defective 
activity of this process result in pathological outcomes (Mizushima et al., 2008). 
Autophagic defects were shown to play a role in a broad number of human diseases, 
including neurodegenerative disorders, myopathies, heart and liver diseases, infections 
and immune diseases, and cancer (Levine and Kroemer, 2008; Mizushima and Komatsu, 
2011; Schneider and Cuervo, 2014).  
The key players in the autophagic process are a group of evolutionary conserved 
proteins, named autophagy-related (Atg) proteins. When autophagy is induced, Atg 
proteins assemble at specialized sites and initiate the formation of a double membrane 
structure called isolation membrane. This isolation membrane expands and recruits Atg 
proteins and membranes from Golgi, endoplasmic reticulum, endosome, mitochondria 
and/or plasma membrane compartments, to become a phagophore (Boya, Reggiori, and 
Codogno, 2013). Atg9 shuttles between the isolation membrane and the different 
recruitment sites, directing membranes for autophagosome elongation (Feng et al., 2014). 
In mammalian cells, activation of the Beclin 1/class III phosphatidylinositol 3-kinase 
complexes is necessary to initiate the nucleation step of the phagophore. Association of 
Beclin 1 (Becn1, homologue of yeast protein Atg6) with Vps34, Vps15 and Ambra1 to form 
a core complex, and then also with UVRAG, Atg15, Barkor or Rubicon in multiprotein 
complexes, is involved in different functions in membrane trafficking (He and Levine, 
2010). Ulk1/Atg1 kinase, which forms a complex with Atg13 and Atg17, is also a key 
regulator in autophagy initiation step (Mizushima et al., 2010; Kim et al., 2011). As 
detailed below, Ulk1 can be differently regulated by several kinases to modulate cell 
autophagy.  
Following the initiation step, elongation of the phagophore takes place, thus 
generating the characteristic double-layered membrane vesicles called autophagosomes. 
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Two different ubiquitin-like conjugation systems act synergistically to add the Atg12–
Atg5–Atg16L complex and the microtubule-associated light chain protein 3 
(MAPLC3/LC3/Atg8) to the nascent pre-autophagosomal membranes (Ohsumi, 2001; 
Mizushima et al., 2003; Fujita et al., 2008). Atg5 forms a covalent complex with Atg12, 
thanks to Atg7 (an ubiquitin-activating E1 enzyme) and Atg10 (an E2-like enzyme). When 
Atg7 and Atg10 are released, Atg16L can bind the newly formed Atg5-Atg12 complex and 
together they lead to elongation of the pre-autophagosome (Nemoto et al., 2003; Ferraro 
and Cecconi, 2007). At the same time, the cytosolic form of LC3 (called LC3-I) is cleaved by 
Atg4, and its C-terminal residue is transferred to a phosphatidyl ethanolamine (PE) by 
Atg7 (E1-like) and Atg3 (E2-like) enzymatic activities. The conjugation of LC3 with PE 
results in a lipidated, non-soluble form of LC3 (called LC3-II) that is inserted in the pre-
autophagosomal membranes (Ichimura et al., 2000).  
The unique features of the LC3 protein make it the only reliable marker to follow in a 
spatial and temporal manner the formation and the dynamic changes of the 
autophagosomes. Indeed, generation of LC3-II specifically correlates with its insertion in 
the autophagosome membranes, in which this protein remains inserted until fusion with 
lysosomes and degradation (Kabeya et al., 2004; Mizushima and Kuma, 2008; Klionsky et 
al., 2012-guidelines). GFP-LC3 reporter mice are in this context a valuable tool to monitor 
autophagic flux in vivo (Mizushima and Kuma, 2008; Mizushima et al., 2004). LC3 interacts 
with a wide range of proteins containing a specific domain, called LC3-interacting region 
(LIR). Among these interacting factors, the sequestosome-1 protein (p62 or SQSTM1) 
mediates selective degradation of ubiquitinated protein aggregates (Bjørkøy et al., 2006; 
Komatsu et al., 2007; Stolz et al., 2014). Indeed, p62 also contains an ubiquitin binding 
domain thus targeting poly-ubiquitinated proteins to autophagosomal degradation. 
Following fusion with lysosomes, the autophagic adaptor p62 is also degraded. Therefore, 
p62 accumulation is a useful marker for autophagy flux and cell clearance (Stolz et al., 
2014; Klionsky et al., 2012-guidelines). However, the expression of p62 can change at the 
transcriptional level due to many stimuli and conditions, such as nutrient starvation, 
making its interpretation more complex (Jiang and Mizushima, 2014). Furthermore, the 
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assembly of aggregation-prone proteins into large aggregates may also work as nucleation 
sites for the phagophore, promoting their uptake into autophagosomes. The selective 
removal of these aggregates, through specific chaperones or adaptor proteins, is called 
aggrephagy (aggresome-autophagy). Thanks to cargo-specific receptors, autophagosomes 
can selectively sequester and degrade different cargoes, such as mitochondria, 
peroxisomes, endoplasmic reticulum, endosomes, cytoplasmic aggregates, ribosomes and 
pathogens (Stolz et al., 2014; Boya, Reggiori, and Codogno, 2013). The final step of 
autophagosome biogenesis is the sealing of the double membrane phagophore. This 
maturation process is interconnected with the fusion of autophagosome with the 
lysosome, that finally generate the autophagolysosome (or autolysosome) whose content 
is degraded by lysosomal hydrolases and can be recycled by the cell. Lysosomes integrity 
is also fundamental to complete autophagy (Shen and Mizushima, 2014).  
Autophagy is controlled by multiple signaling pathways, most of which converge on 
the mammalian target of rapamycin (mTOR), a master regulator of cell growth. In 
mammalian cells, mTOR complex 1 (mTORC1) is controlled by the nutrient status of the 
cell and by the availability of amino acids and growth factors (Russell et al., 2014). In 
physiological  condition, mTORC1 negatively regulates autophagy by binding and 
phosphorylation of the Ulk1 complex at Ser 757, the major mTORC1 phosphorylation site 
in vivo, thus disrupting its interaction with AMP-activated protein kinase (AMPK) (Kim et 
al., 2011; Shang and Wang, 2011). Conversely, when nutrients are scarce and/or ATP 
concentration is decreased, mTORC1 is inhibited leading to autophagy re-activation. 
Energy consumption leads to AMPK auto-phosphorylation. Active AMPK can subsequently 
trigger autophagy both by inhibiting mTOR and activating Ulk1 through phosphorylation 
(Egan et al., 2011; Boya, Reggiori, and Codogno, 2013). Moreover, mTORC1 regulates 
autophagy at the level of Atg gene transcription, acting on downstream translational 
regulators, such as the initiation factor 4E binding protein (4E-BP1) and the p70 S6 kinase 
(p70S6K, that in turn phosphorylates the S6 ribosomal protein).  
Autophagy can be modulated also by controlling lysosome biogenesis, through 
mTORC1 regulation of the transcription factor EB (TFEB). TFEB is a master gene regulator 
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of several lysosomal and autophagy-related genes (Settembre and Ballabio, 2011). It 
localizes to the lysosome membrane together with mTORC1, whose phosphorylation leads 
to TFEB cytoplasmic sequestration. When mTORC1 is inactive, the dephosphorylated 
TFEB can migrate to the nucleus where it exerts its pro-transcriptional activity 
(Settembre et al., 2012; Martina et al., 2012). TFEB controls lysosomal biogenesis by 
positively regulating genes belonging to the Coordinated Lysosomal Expression and 
Regulation (CLEAR) network, and controls autophagosome biogenesis by direct targeting 
the promoters of several Atg genes, such as UVRAG, MAPLC3B, SQSTM1 and ATG9B 
(Sardiello et al., 2009; Settembre et al., 2011). 
Thus, mTOR has a major role in adapting cell metabolism in response to nutrient 
sensing, interacting with main autophagy regulators and impinging both on autophagy 
initiation and maturation steps (Russell et al., 2014). Furthermore, via the mTOR pathway, 
also lysosomes show a crucial role in modulating the TFEB response, and hence the 
cellular response to nutrient changes (Settembre et al., 2011). 
 
1.4. Extracellular matrix regulation of autophagy 
In all tissues and specialized microenvironments, ECM-derived signals are crucial for 
cytoprotection and homeostasis, in some cases converging to the autophagic machinery 
(Neill et al., 2014). The role of the ECM on the regulation of autophagy is still under 
dissection. However, increasing evidence was recently provided regarding the 
involvement of ECM proteins (Nguyen et al., 2007; Grumati et al., 2010; Castello-Cros et 
al., 2011; Tuloup-Minguez et al., 2011; Buraschi et al., 2013) and of integrin receptors 
(Fung et al., 2008; Tuloup-Minguez et al., 2013) in autophagy signaling, thus opening the 
field for further studies.  
Epithelial cell survival depends on integrin-mediated adhesion to ECM. Upon matrix 
detachment, cells undergo a form of cell death called anoikis. Integrin disengagement is 
also able to trigger autophagy, as a prosurvival mechanism to skip anoikis in a non-
tumorigenic manner. The reduced growth factor sensing by membrane receptors results 
in autophagy induction, despite of addition of other nutrients (Fung et al., 2008). In this 
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Akt/mTOR axis. Thus, decorin induces autophagy via a canonical Vps34/mTOR pathway 
by acting on a novel identified regulator of macroautophagy, Peg3 (Buraschi et al., 2013; 
Goyal et al., 2014).  
Other ECM macromolecules, such as collagen types I and IV, display a role in 
autophagy modulation when present as adhesion substrates, but a mechanistic insight is 
still lacking (Tuloup-Minguez et al., 2011).  
In addition, ECM modulation of autophagy often takes place in a nutrient availability 
independent manner, suggesting an intrinsic ability to supervise and constrain 
extracellular factors that triggers this catabolic response, in order to harmonize cell 
responses (Neill et al., 2014). 
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2. Methods 
2.1. Cell culture and transfection. 
Primary mouse embryonic fibroblasts (MEFs) were prepared by dissociation of 13.5 
dpc mouse embryos from wild type (WT) C57BL/6 and Col6a1–/– pregnant female mice. 
MEFs at culture passage 2-4 were grown to 90% confluence in complete Dulbecco’s 
modified Eagle’s medium (DMEM) without antibiotics. Cells were harvested with 0.25% 
trypsin-EDTA (Life Technologies, Gibgo) and resuspended at a final density of 2.4 x 106 
cells/ ml in buffer of the Microporation Solution Kit (MPK-10096, Digital Bio) together 
with 0.5 µg pMSE plasmid encoding for SV40 large T-antigen (SV40LT, kindly provided by 
Prof. M. Sandri, University of Padova). MEFs were then microporated with a 10 µl Gold Tip 
(Neon® Transfection System, MPT100, Life Technologies) at 1500 V for 20 millisec with 
the Microporator MP-100 Platform (Digital Bio), plated in 24-well plates prefilled with 
DMEM containing 10% fetal bovine serum (FBS, Life Technologies) without antibiotics 
and grown at 37° C in a humidified incubator with 5% CO2. Cells were clonally diluted and 
passed for an additional 10 passes to ensure stable immortalization. We obtained at least 
three different WT and three different Col6a1–/– immortalized fibroblast lines. MEFs were 
cultured in DMEM supplemented with 10% FBS and maintained in a humidified incubator 
containing 5% CO2 at 37° C. For collagen VI expression studies, cells were cultured three 
to seven days in DMEM containing 10% FBS supplemented with 0.25 mM ascorbic acid. 
GFP-LC3 stably expressing MEFs lines were generated from GFP-LC3 (kindly provided by 
Prof. N. Mizushima, University of Tokyo) and GFP-LC3;Col6a1–/– transgenic mice. When 
indicated, cells were plated on plastic coated with 5 µg/cm2 purified murine native 
collagen VI (Irwin et al., 2003) or collagen I (Sigma-Aldrich, C8919) and cultured for three 
days. 0.8 x 105 cells were plated on 12 mm glass coverslips, grown to 80% confluence and 
transfected with pMitoRed (kindly provided by Prof. L. Scorrano, University of Padova), 
mCherry-Parkin (Addgene plasmid 23956), YFP-Parkin (Addgene plasmid 23955, 
Narendra et al., 2008) or GFP-TFEB (kindly provided by Prof. M. Sandri, University of 
Padova) using LipofectamineTM LTX (Life Technologies) in a 1:1 ratio, according to 
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manufacturer’s guidelines. After 4 hr, transfected cells were washed in complete DMEM 
without antibiotics and cultured 18-20 hr before fixation. When indicated, the following 
additional treatments were used on 80% confluent cells: 3 hr or 6 hr serum starvation; 50 
μM chloroquine (Sigma-Aldrich); 250-500 mM 3-methyladenine (3-MA, Sigma-Aldrich). 
Finally, cells were harvested and processed for FACS analysis or fixed for 10 min with ice-
cold acetone/methanol (1:1) at -20° C. Carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) was from Sigma. 
2.2. Immunofluorescence on cells.  
Fixed cells were washed three times in PBS, blocked with 10% goat serum (Sigma) for 
30 min and incubated for 2 hr at room temperature or overnight at 4° C with the following 
primary antibodies: rabbit anti-collagen VI (AS72, kindly supplied by Prof. A. Colombatti, 
CRO Aviano), mouse anti-fibronectin (kindly supplied by Prof. A. Colombatti, CRO Aviano), 
rabbit anti-α1(VI) (Santa Cruz Biotechnology), guinea pig anti-α3(VI) (kindly supplied by 
Prof. R. Wagener, University of Cologne), rat anti-LAMP-2 (GL2A7, ab13524 Abcam), 
rabbit anti-LC3B (2775, Cell Signaling Technologies), rabbit anti-Tom20 (Santa Cruz 
Biotechnology). After three washing in PBS, slides were incubated for 1 hr with the 
following secondary antibodies: anti-mouse CY2, anti-rabbit CY2, anti-rabbit CY3, anti-rat 
CY3 (all Jackson Immunoresearch); IRIS anti-rabbit CY5.5 (Cyanine Technologies). Nuclei 
were stained with Hoechst 33258 (Sigma-Aldrich). Slides were mounted in 80% glycerol-
PBS and analyzed with a Leica SP5 confocal microscope. Colocalization was quantified in 
merged images, after thresholding of individual frames, using the JACoP plugin of ImageJ 
(NIH). The percentage of cells with enlarged lysosomes was calculated by manual 
counting of the cells with at least two enlarged LAMP-2-positive lysosomes on total cell 
number per field, for thirty randomly chosen image fields. The percentage of cells with 
tubular or fragmented mitochondria was estimated by manual classification of 
mitochondrial morphology in at least thirty randomly chosen fields. Mean data are 
representative of at least five independent biological samples. 
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2.3. TUNEL assay.  
Terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling (TUNEL) 
analysis was performed on acetone/methanol fixed MEFs using the Dead End 
Fluorometric In Situ Apoptosis Detection System (Promega). MEFs, grown on slides and 
fixed in acetone/methanol, were washed and incubated for 10 min with the equilibration 
buffer. Then the slides were incubated with a buffer containing fluorescent nucleotides, 
terminal deoxynucleotidyl transferase (TdT), and Hoechst 33258 (Sigma) for 1 hr at 37°C. 
The reaction was blocked with SSC solution (300 mM NaCl, 30 mM sodium citrate). After 
being washed three times in PBS, slides were mounted using 80% glycerol. Hoechst was 
used to counterstain all nuclei and TUNEL-positive nuclei were determined by counting 
randomly selected fields using a Zeiss Axioplan microscope. 
2.4. Flow cytometry.  
Wild type and Col6a1–/– MEFs were plated (200,000 cells/ well) in 12-well plates by 
adhesion on plastic, purified collagen VI or collagen I and cultured for a day. Cells were 
washed in PBS, and incubated for 3 hr or 6 hr in complete medium or in serum-free 
medium. When indicated, 1 μM staurosporine (STS) or 250-500 mM 3-methyladenine (3-
MA, Sigma-Aldrich) were added to the serum-free medium. Apoptosis was determined 
using the Annexin V-FITC Apoptosis detection kit (eBioscience). Cells were harvested, 
washed with PBS and incubated in 195 μl of 1x binding buffer containing 5 μl annexin V-
FITC for 15 min at room temperature in the dark according to the manufacturer’s 
protocol. Cells were finally incubated with 1 μg/ μl propidium iodide (PI) and samples 
were immediately analyzed on a FACSCanto flow cytometer equipped with FACS Diva 
software (BD Biosciences), using the FL-1 and the FL-2 settings. Forward scatter and side 
scatter (morphology parameters) were performed to discriminate live cells (annexin V 
negative and PI negative), apoptotic cells (annexin V positive) and necrotic cells (annexin 
V negative and PI positive). For each sample 10,000 events were collected, for five 
independent biological replicates. Results were analyzed using Flowing Software v2.5.0 
(Turku Centre for Biotechnology, University of Turku). 
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2.5. Quantitative RT-PCR (qRT-PCR).  
500,000 MEFs of each genotype were plated in 6-well plates, in triplicate, and 
cultured for 2 days (autophagy studies) or 4 days (collagen VI expression). For the 
analysis of Col6a1, cells were cultured until post-confluence in DMEM containing 10% 
FBS, in the presence or absence of 0.25 mM ascorbic acid. For the analysis of autophagy 
genes, cells were washed in PBS, then media with or without FBS was replaced for 3 hr. 
RNA extraction was performed by adding 1 ml/well TRIzol Reagent (Life Technologies) 
directly on MEFs and following the manufacturer’s protocol. RNA was quantified using a 
Nanodrop ND-1000 instrument (Nanodrop Technologies) and 1 µg total RNA was 
retrotranscribed using the SuperScript III First-Strand Synthesis System for RT-PCR (Life 
Technologies), following manufacturer’s instructions. Resulting cDNAs were used to 
perform quantitative real time PCR using Rotor-Gene SYBR Green PCR Kit mastermix 
(Qiagen) with the RotorGeneQ instrument (Qiagen). Primer  sequences are shown in 
Table 1. 
2.6. Western blotting.  
MEFs (0.5 x 106 cells/ ml) were cultured in 6-well plates for three days. When 
indicated, multiwell plates were coated with 5 µg/cm2 collagen VI or collagen I as 
described above. Cells were washed once in PBS and harvested with a cell lifter in lysis 
buffer (100 µl 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20 mM EDTA, 0.5% NP40) 
supplemented with phosphatase inhibitors (Cocktail II P5726, Sigma-Aldrich) and 
proteases inhibitors (Complete EDTA free, Roche). Cell lysates were then sonicated twice 
for 15 sec using a Bioruptor (Diagenode) and the cleared cell lysates were quantified with 
the BCA Protein Assay kit (Pierce). SDS-PAGE of protein lysates (20 or 30 µg) was 
performed using 3-8%, 4-12%, 10% or 12% polyacrylamide Novex NuPAGE Bis-Tris gels 
(Invitrogen) and electrotransferred onto PDVF membrane (Millipore). Membranes were 
blocked for 1 hr in 5% milk in TBST and incubated 1 hr at room temperature or overnight 
at +4° C with the following primary antibodies diluted 1:1000 in TBST, 5% BSA: anti-
AMPK; anti-phospho-AMPK (Thr172), anti-Akt, anti-phospho-Akt (Ser473), anti-ERK1/2, 
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anti-Ulk1, anti -phospho-Ulk1 (Ser757 and Ser555), anti-4E-BP1, anti-phospho-4E-BP1, 
anti-S6, anti-phospho-S6, anti-Raptor, anti-phospho-Raptor (all Cell Signaling 
Technologies); guinea pig polyclonal anti-p62 (Progen); rabbit polyclonal anti-LC3B; 
rabbit polyclonal anti-Atg5 (Sigma-Aldrich); rat anti-LAMP-2 (Abcam); mouse monoclonal 
anti-β-actin (Chemicon International). Membranes were then washed three times and 
incubated for 1 hr at room temperature with HRP-conjugated secondary antibodies 
(Amersham Bioscience) diluted 1:1000 in TBST and 5% milk. Detection was performed by 
SuperSignal West Pico or Dura Chemiluminescent Substrate and CL-X Posure Film 
(Thermo Scientific), with β-actin as a loading control. When needed, membranes were 
stripped using a stripping buffer (25 mM glycine, 1% SDS, pH 2.0) and re-probed. Western 
blots were performed in at least three independent experiments. Densitometric 
measurements were obtained using ImageJ software (NIH), normalizing the signal of each 
band to the corresponding actin band or to the non-phosphorylated form of protein. We 
calculated the difference between the ratios of LC3 conversion (LC3-II/LC3-I) as an 
indicator of the rate of the autophagy flux: this difference was calculated as the ratio of 
LC3-II/LC3-I values obtained in basal condition, onto LC3-II/LC3-I values obtained after 
serum starvation:  
 
We defined this difference as serum-induced conversion rate of LC3. 
2.7. Statistical analysis.  
All results are expressed as means ± s.e.m. Statistical analysis of data was performed 
with Student’s t test for unpaired data and a P<0.05 was considered statistically 
significant (*, P<0.05; **, P<0.01; ***, P<0.001). 
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3. Results 
3.1. Immortalized MEFs produce collagen VI and organize an extracellular matrix 
We first investigated the ability of immortalized MEFs to produce ECM proteins like 
collagen VI and fibronectin. Immunofluorescence using antibodies against whole collagen 
VI showed the deposition and the formation of organized filaments of collagen VI in the 
extracellular matrix of wild type MEFs, but not of Col6a1–/– MEFs (Fig. 1A). Fibronectin 
staining was detected in the extracellular matrix of both wild type and Col6a1–/– MEFs. As 
expected (Sabatelli et al., 2001; Tillet et al., 1994), collagen VI and fibronectin fibrils did 
not colocalize, but they were strictly interconnected in the extracellular matrix of wild 
type MEFs (Fig. 1A).  
Culture media and cell extracts from wild type and Col6a1–/– MEFs that were grown 
from three to five days in 6-well plates, were separated by SDS-PAGE under reducing 
conditions and labeled with antibodies against either α1(VI) or α3(VI) collagen subunits 
(Fig. 1B). Cells were treated with ascorbic acid to promote collagen VI secretion in the 
extracellular environment. The α1(VI) chain was detected as a band at 140 kDa in culture 
media and cell extracts of wild type MEFs, but not of Col6a1–/– MEFs, in agreement with 
the complete null mutation of the corresponding Col6a1 gene in homozygous knockout 
mice (Fig. 1B). In culture media and cell extracts of wild type MEFs, α3(VI) was detected 
as two major bands. The α3(VI) chain was abundantly present in wild type cell extracts 
and ascorbic acid treatment increased its secretion outside the cell. In culture media of 
Col6a1–/– MEFs, the α3(VI) chain was not detected except for a faint band below the 270 
kDa marker. Cell extracts of Col6a1–/– MEFs displayed very low levels of α3(VI) (Fig. 1B, 
C). These data are in agreement with previous studies in Col6a1–/– mice, showing that in 
the absence of α1(VI) the other two chains are still expressed but cannot assemble nor 
lead to the secretion of functional collagen VI polypeptides.  
To further investigate the expression of collagen VI in the immortalized MEFs, we 
performed qRT-PCR for the three collagen VI genes (Fig. 1C). Wild type MEFs expressed 
high levels of Col6a1, Col6a2 and Col6a3 transcripts. Treatment with ascorbic acid had no 
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significant effects on transcripts, except for α3(VI) mRNA that appeared increased. As 
expected, Col6a1 mRNA in was almost undetectable in Col6a1–/– MEFs. Interestingly, 
Col6a3 transcript levels were also decreased in Col6a1–/– MEFs, whereas Col6a2 mRNA 
levels were similar in wild type and Col6a1–/– MEFs (Fig. 1C).  
Given the presence of discrete amounts of intracellular α2(VI) and α3(VI) 
polypeptides in Col6a1–/– cells, we assessed whether the non-secreted single collagen VI 
chains are degraded through the autophagic pathway and are found into autophagosomes, 
which are accumulated in these cells as explained in detail below. However, we did not 
detect any co-localization of intracellular α3(VI) and autophagosome dots, suggesting that 
the unassembled collagen VI chains are eliminated by other mechanisms (Suppl. Fig. S1).  
 
3.2. Autophagy is blocked at terminal stages in Col6a1–/– MEFs.  
To examine whether autophagy was affected in Col6a1–/– MEFs, we studied 
autophagosome formation by evaluating LC3 conversion to its lipidated form and by 
monitoring protein degradation by consumption of p62, both in complete medium and 
after 3 hr serum withdrawal. Western blotting showed decreased LC3-I to LC3-II 
conversion (LC3-II/LC3-I ratio) in Col6a1–/– MEFs after serum withdrawal (Fig. 2A). 
However, total LC3-II protein content was not reduced per se when compared to the 
respective wild type condition. To investigate the autophagic flux we treated cells with 
chloroquine, an inhibitor of lysosome acidification. Interestingly, in wild type MEFs LC3-
II/LC3-I ratio was increased both after starvation (two-fold increase) and in the presence 
of chloroquine, indicating an increase in autophagosome formation and autophagy 
induction (Fig. 2B, C). Differently, Col6a1–/– MEFs displayed only a small increase of the 
LC3-II/LC3-I ratio after serum starvation and no increase after chloroquine treatment 
(Fig. 2B, C). The results obtained by these experiments indicate that endogenous LC3 
protein is accumulating in Col6a1–/– fibroblasts and that LC3-II conversion rate is 
decreased in Col6a1–/– cells when compared to wild type MEFs (Fig. 2).  
To understand further the autophagic process in collagen VI deficient MEFs, we 
generated immortalized MEFs lines from GFP-LC3 and GFP-LC3;Col6a1–/– transgenic mice 
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and measured autophagosome formation by detection of GFP-positive puncta in cells 
maintained in complete medium or subjected to 3 hr serum withdrawal. In GFP-LC3 
fibroblasts, few GFP-positive puncta formed in complete medium, while a six-fold increase 
of GFP-positive puncta was detected after serum withdrawal. In both conditions, 50 µM 
chloroquine treatment led to a marked accumulation of autophagosomes (Fig. 2D, E). In 
GFP-LC3;Col6a1–/– fibroblasts, we detected a massive formation of GFP-positive puncta 
already in complete medium conditions. In addition, no substantial variation in the 
number of fluorescent puncta was found in GFP-LC3;Col6a1–/– MEFs after serum 
starvation or following treatment with chloroquine. Moreover, GFP-positive 
autophagosomes were larger in collagen VI null fibroblasts when compared to wild type 
MEFs (Fig. 2D). These results suggest that the increased number and size of 
autophagosomes in Col6a1–/– fibroblasts may rely upon a slower “off rate” in the 
autophagic flux rather than an increase in autophagosome formation. Western blotting 
showed a decrease of p62 levels in Col6a1–/– MEFs , whereas total amounts of the Atg5-
Atg12 conjugation complex increased in a similar manner in wild type and Col6a1–/– cells 
following serum starvation (Fig. 2A).  
Gene expression analysis by qRT-PCR showed that p62 transcript levels were 
consistently down-regulated in Col6a1–/– MEFs, independently on serum starvation. Also 
the transcriptional activation of LC3 was defective in Col6a1–/– fibroblasts, as we did not 
detect any significant increase of LC3 mRNA levels after serum starvation, at difference 
from wild type MEFs (Fig. 2F). The mRNA levels of two other autophagic regulators, 
BNIP3 and Beclin 1, were not significantly affected by these experimental conditions or in 
the Col6a1–/– context (Suppl. Fig. S3). 
 
3.3. AMPK is hyperactivated in Col6a1–/– MEFs, leading to a mild autophagy 
induction, but a residual activity of mTOR signaling is present. 
Considering the latent mitochondrial dysfunction previously observed in Col6a1–/– 
myofibers (Irwin et al., 2003; Grumati et al., 2010), we investigated the activation state of 
AMP-activated protein kinase (AMPK), a sensor of energy status of the cell that becomes 
 
 
 
26 
 
Results Part I       
active under metabolic stress (Russell et al., 2014). AMPK phosphorylation was noticeably 
increased in Col6a1–/– MEFs, especially in basal conditions but also under serum 
starvation, indicating a general energy impairment (Fig. 3A). We analyzed the activation 
of extracellular signal-regulated kinases 1 and 2 (Erk1/2), two kinases acting on 
autophagy, and found that both Erk kinases were much less phosphorylated in Col6a1–/– 
MEFs compared to wild type MEFs both in basal conditions and after serum starvation 
(Fig. 3B). 
Since the AMPK/Ulk1/mTORC1 signaling is essential for the autophagic response to 
nutrients (Russell et al., 2014), we further analyzed AMPK-dependent Ulk1 activation, by 
investigating Ulk1 phosphorylation on Ser 555 (Egan et al., 2011), and mTOR-dependent 
Ulk1 inactivation due to Ser 757 phosphorylation (Shang and Wang, 2011). Interestingly, 
we found that in both cases Ulk1 phosphorylation persisted after serum withdrawal in 
Col6a1–/– MEFs but not in wild type MEFs (Fig. 3A, C). Furthermore, the mTOR axis was 
persistently activated in Col6a1–/– MEFs after serum withdrawal, as demonstrated by 
phosphorylation of 4E-BP1 and of the S6 ribosomal protein, two major downstream 
targets of mTORC1 (Fig. 3C). 
 
3.4. Adhesion onto collagen VI affects autophagy regulation in MEFs. 
To evaluate whether addition of collagen VI was capable to impinge on the defective 
autophagy of Col6a1–/– MEFs, we cultured fibroblasts onto purified collagen VI provided 
as an adhesion substrate for three days, and then subjected cells to serum starvation. 
Growth of MEFs onto native collagen VI elicited an effect on LC3 lipidation and Ulk1 
phosphorylation in both wild type and Col6a1–/– MEFs (Fig. 4). In particular, analyses of 
LC3-II/LC3-I ratios after western blotting showed that the serum-induced conversion rate 
of LC3 was increased in wild type MEFs, and a trend toward the increase was also found in 
Col6a1–/– MEFs (Fig. 4A-C). However, LC3 degradation in Col6a1–/– MEFs was enhanced in 
presence of collagen VI (Fig. 4A), leading to the rescue of LC3 accumulation in these cells 
(Fig. 2B). We also analyzed Ulk1 phosphorylation, in particular its mTOR-dependent 
inhibitory phosphorylation at Ser 757 that was found to be more phosphorylated in 
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Col6a1–/– MEFs (Fig. 3C), leading to Ulk1 inhibition in starving Col6a1–/– MEFs. 
Interestingly, after coating on collagen VI, Ulk1 phosphorylation in serum-starved 
condition was reduced also in Col6a1–/– MEFs (Fig. 4A, D). In wild type MEFs coated on 
collagen VI, Ulk1 phosphorylation was higher in basal conditions, and after serum 
depletion it decreased.  
 
3.5. Lack of collagen VI affects lysosomes morphology and impairs autophagosome-
lysosome fusion. 
Based on the results discussed in § 3.2, which suggested an impairment of the “off 
rate” of the autophagic flux in Col6a1–/– MEFs, we analyzed lysosomes and their fusion 
with autophagosomes. Unexpectedly, immunostaining with the lysosomal marker LAMP-2 
revealed a large amount of enlarged lysosomes in Col6a1–/– fibroblasts, whereas in wild 
type MEFs lysosomes appeared as smaller punctuate structures (Fig. 5A, B). Similarly 
enlarged lysosomes were detectable after serum depletion or following chloroquine 
treatment in wild type cells (Fig. 5B, Suppl. Fig. S2). Moreover, the increased number of 
enlarged lysosomes in Col6a1–/– MEFs appeared to be independent on autophagy 
induction by serum starvation (Fig. 5B). Wild type MEFs showed an increased number of 
enlarged lysosomes after serum depletion, that however was always of lesser extent when 
compared to Col6a1–/– cells (Fig. 5B). Interestingly, LAMP-2 protein levels were decreased 
in Col6a1–/– MEFs when compared to wild type MEFs, however LAMP-2 retained the 
capability to increase its levels in response to serum depletion (Fig. 5C, D). The decrease 
of LAMP-2 protein levels in Col6a1–/– MEFs was not paralleled by a reduction of LAMP-2 
gene expression, which was also not influenced by serum depletion (Fig. 5E). 
We further analyzed the final stages of fusion between autophagosomes and 
lysosome, by coimmunostaining for LC3 and LAMP-2. In wild type MEFs, colocalization of 
autophagosomes with lysosomes, indicating fusion events, was almost doubled upon 
serum depletion-induced autophagy (Fig. 5F). Notably, in Col6a1–/– MEFs colocalization of 
LAMP-2 and LC3 was not affected by serum depletion, indicating defective 
autophagosome-lysosome fusion (Fig. 5F, G). We also studied LAMP-2 
 
 
 
28 
 
Results Part I       
immunolocalization on immortalized MEFs lines derived from GFP-LC3 transgenic mice, 
and obtained similar results for GFP-LC3;Col6a1–/– MEFs (data not shown). 
It is well established that the transcription factor TFEB is a master regulator for 
lysosomal biogenesis, coordinating autophagy regulation to lysosomal biogenesis and 
function (Sardiello et al., 2009; Settembre et al., 2011) To evaluate whether TFEB 
contributed to the lysosomal defects found in Col6a1–/– MEFs, we investigated its cellular 
localization after transfection of a GFP-TFEB construct in MEFs. As expected (Settembre et 
al., 2012), in wild type MEFs subjected to 3 hr serum depletion, the expressed GFP-TFEB 
transgene translocated from the cytosol to the nucleus (Fig. 6A, B), Differently, in Col6a1–
/– MEFs the cellular localization of GFP-TFEB was markedly affected. In basal condition 
(complete medium), a sizeable fraction of GFP-TFEB was already seen in the nucleus in 
Col6a1–/– MEFs. Conversely, following serum depletion GFP-TFEB translocated to the 
nucleus only in a small fraction of Col6a1–/– MEFs (Fig. 6A, B). 
 
3.6. Collagen VI ablation causes apoptotic cell death via caspase activation. 
It is widely recognized that defects of autophagy impinge on cell survival and may 
lead to increased apoptosis and cell death. To evaluate the incidence of apoptosis in the 
immortalized wild type and Col6a1–/– MEFs, we first performed TUNEL assay. Apoptotic 
nuclei were markedly increased in collagen VI null fibroblasts (Fig. 7A). Notably, adhesion 
of cells onto purified collagen VI significantly rescued the apoptotic defects of Col6a1–/– 
MEFs, an effect which was not displayed by collagen type I, used as a control extracellular 
matrix substrate (Fig. 7A). The increased apoptosis incidence of Col6a1–/– MEFs was 
further confirmed by flow cytometry studies of annexin V and PI labeled cells (Fig. 7B, C). 
Col6a1–/– MEFs were less viable when compared to wild type MEFs, both under basal 
conditions and after 3 hr or 6 hr of serum depletion (Fig. 7B and data not shown). 
Furthermore, not only early apoptotic events, but also late apoptosis/ necrosis events 
(annexin V-FITC positive and PI positive cells) were increased in Col6a1–/– fibroblasts 
(Fig. 7C).  
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Interestingly, three days of culture onto native collagen VI significantly ameliorated 
the survival of Col6a1–/– MEFs both under basal conditions and after serum withdrawal. 
By contrast, when cultured onto a control coating made of collagen I, Col6a1–/– MEFs did 
not rescue cell viability after serum withdrawal (Fig. 7B, C). Adhesion onto collagen VI 
also elicited some beneficial effects on wild type cells, since apoptotic cells (annexin V 
positive) were significantly decreased when wild type MEFs were grown on collagen VI 
(Fig. 7C).  
The above findings, together with the occurrence of a large number of aggregated 
autophagosomes in Col6a1–/– MEFs, suggest the possibility that an autophagic cell death 
may occur in this context. To test this hypothesis, we investigated autophagic cell death by 
treating cells with the autophagy inhibitor 3-MA in order to prevent the accumulation of 
autophagosomes and lysosomes. Notably, 3 hr treatment with 3-MA led to a dose-
dependent increase of cell death both in wild type and in Col6a1–/– MEFs (Suppl. Fig. S4), 
thus excluding the possibility of an autophagic cell death. Next, we evaluated caspase 
activation by western blotting, and found that cleaved caspase 3 and 9 were present in 
Col6a1–/– MEFs (Fig. 7D). Moreover, the activated forms of both caspases were further 
increased by serum depletion in Col6a1–/– fibroblasts, similarly to the staurosporine-
treated positive controls (Fig. 7D). 
 
3.7. Col6a1–/– MEFs display fragmented mitochondria and mitophagy alterations.   
As previously found in cell cultures derived from muscle biopsies of UCMD patients 
(Sabatelli et al., 2012), Col6a1–/– MEFs displayed highly fragmented mitochondria with 
respect to wild type MEFs (Fig. 8A). We labeled mitochondria with different probes, using 
MitoTracker, pMitoRed and Mito-YFP plasmids, and consistently found that fragmented 
mitochondria were more than two-fold increased in Col6a1–/– MEFs when compared to 
the corresponding wild type MEFs (Fig. 8A, B). 
We then analyzed the efficiency of mitochondria removal by selective autophagy, 
namely mitophagy, by performing coimmunolocalization studies of mitochondria and 
autophagosomes/autolysosomes after serum withdrawal. Towards this aim, we used GFP-
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LC3 MEFs and stained mitochondria with Tom20 and lysosomes with LAMP-2. First of all, 
we confirmed a defect in mitochondria elongation and a decrease in autophagosome-
lysosome fusion in Col6a1–/– MEFs (Fig. 8C, D). Then, interestingly, we noticed an 
increased rate of colocalization between mitochondria and autophagosomes/lysosomes in 
Col6a1–/– MEFs (Fig. 8C, D). To experimentally test if mitochondrial removal by autophagy 
was functional in Col6a1–/– MEFs, we transfected cells with a YFP-Parkin construct 
(Narendra et al., 2008) and with pMitoRED plasmid (Fig. 8E). Interestingly, we found that 
YFP-Parkin was more frequently translocated to mitochondria in Col6a1–/– MEFs (more 
than ten-fold increase with respect to wild type MEFs) already in basal condition when 
complete medium was available (Fig. 8F). Mitochondria removal was estimated by 
monitoring Tom20 immunostaining after 24 hr of CCCP treatment (20 µM), used as 
mitochondrial uncoupler. We found that the mitochondrial pool was decreased in wild 
type MEFs after the CCCP-induced damage. Conversely, in Col6a1–/– MEFs the decrease of 
mitochondrial pool was lower (Fig. 8G). 
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4. Discussion 
Collagen VI is an ECM protein forming a distinct microfibrillar network in most 
interstitial connective tissues including skin, cartilage, tendons, adipose tissue (Braghetta 
et al., 1996; Kuo et al., 1997; Keene et al., 1988; Khan et al., 2009). This ECM protein is 
concentrated near the basement membranes of several organs such as skeletal muscle, 
blood vessels and peripheral nerves (Kuo et al., 1997). Notably, collagen VI is one of the 
major ECM component produced by human skin fibroblasts, together with collagen I and 
III (Olsen et al., 1989).  
A powerful tool to investigate the in vivo functions of collagen VI was provided by the 
generation of a knockout mouse model for collagen VI (Col6a1–/–), through gene-targeted 
inactivation of Col6a1 gene (Bonaldo et al., 1998). Col6a1–/– mice display a distinctive 
phenotype with structural and functional defects of skeletal muscles and represent a 
valuable animal model of human collagen VI-related pathologies, including UCMD and BM 
(Bonaldo et al., 1998; Irwin et al., 2003; Grumati et al., 2010). The first characterization of 
Col6a1–/– mice revealed a myopathic phenotype affecting primarily diaphragm and other 
skeletal muscles, with degeneration of myofibers and reduced strength (Bonaldo et al., 
1998). Electron microscopy analyses of Col6a1–/– muscles demonstrated ultrastructural 
alterations of sarcoplasmic reticulum and mitochondria, associated with a latent 
mitochondrial dysfunction and spontaneous apoptosis of myofibers (Irwin et al., 2003). 
Further studies were carried out in muscle biopsies and primary muscle cell cultures 
derived from UCMD and BM patients, which demonstrated similar alterations to those 
found in Col6a1–/– mice (Angelin et al., 2007). A highly influential study later 
demonstrated a failure of the autophagic process in collagen VI deficient muscles. Of note, 
this autophagic impairment plays a key pathogenic role in the onset of the myopathic 
phenotype. Indeed, failure to maintain a proper autophagic flux in Col6a1–/– myofibers 
causes retention of dysfunctional organelles and ultimately leads to myofiber apoptosis 
and degeneration (Grumati et al., 2010). Furthermore, in vivo reactivation of a proper 
autophagic flux in Col6a1–/– muscles by different nutritional, pharmacological or genetic 
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approaches is highly beneficial and allows to rescue muscle structure and function 
(Grumati et al., 2010). A more recent study, to which I collaborated before starting my 
PhD, showed that physical exercise promotes autophagy induction in skeletal muscle. Of 
note, physical training is unable to reactivate autophagic flux in Col6a1–/– muscles, leading 
instead to adverse effects and exacerbation of the muscle defects (Grumati et al., 2011). 
Various in vitro and in vivo studies in Col6a1–/– mice showed that lack of collagen VI 
has a strong impact on cell homeostasis and survival process, including apoptosis, cell 
differentiation, autophagy, stem cell niche and regeneration (Irwin et al., 2003; Iyengar et 
al., 2005; Grumati et al., 2010; Urciuolo et al., 2013). Collagen VI exerts a cytoprotective 
role in various cellular contexts and after different cell stresses, such as starvation, 
oxidative stress, Aβ peptide toxicity and injury (Irwin et al., 2003; Grumati et al., 2010; 
Menazza et al., 2010; Cheng et al., 2009; Cheng et al., 2011). These findings highlight a key 
role of this ECM component in cell survival.  
Generation of the Col6a1–/– mouse model was aimed at investigating the in vivo 
biological roles of collagen VI in the different tissues. During the past decade the main 
interest was focused on skeletal muscle given the relevant implications for human 
collagen VI-related myopathies. Although collagen VI clearly exerts a key role in muscle 
homeostasis, the protein is not synthesized by myofiber or by myoblasts. Previous work 
showed that expression of the Col6a1 gene is finely regulated in a dynamic manner 
through a complex set of different transcription regulatory elements extending for about 
10 kb upstream the Col6a1 translated region (Braghetta et al., 1996). Studies in transgenic 
mice expressing different Col6a1 5’-flanking regions fused to the lacZ reporter gene 
showed that expression of the Col6a1 in skeletal muscle is conferred by an enhancer 
element located at about –5 kb from the Col6a1 transcription start site (Braghetta et al., 
2008). Interestingly this enhancer has a strong activity in muscle fibroblasts, but not in 
myogenic cells, and activation of the –5kb Col6a1 enhancer in interstitial fibroblasts of 
developing muscles requires the presence of the myogenic cells (Braghetta et al., 2008). 
These findings point at a strict regulation of collagen VI expression and deposition in 
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muscles, where interstitial fibroblasts produce and secrete the protein in response to 
specific signals generated by the myogenic cells. This is also confirmed by studies with 
muscle-derived cultures containing both myoblasts and fibroblasts, showing that 
fibroblasts abundantly secrete collagen VI and organizes it into a microfibrillar network 
which takes contact with the surface of myogenic cells (Urciuolo et al., 2013). In vitro 
studies showed that muscle primary cultures do not produce and secrete collagen VI into 
the ECM until muscle-derived fibroblasts are reintroduced in the culture (Zou et al., 2008). 
Furthermore, studies in cell cultures from UCMD and BM patients showed that the 
mutated form of collagen VI is synthesized and retained by fibroblasts (Pan et al., 2003; 
Zou et al., 2008). Nevertheless, once secreted in the interstitial space, fibroblast-produced 
collagen VI tightly interacts with myofibers, thus explaining its biological functions deeply 
interconnected with muscle homeostasis (Zou et al., 2008). Therefore, and at difference 
from other muscular dystrophies and inherited muscle disorders, collagen VI myopathies 
represent a unique type of non-cell-autonomous diseases of skeletal muscles, since the 
mutated protein downstream the primary genetic defect is not found or produced by the 
myofibers themselves, but by fibroblasts (Bönnemann, 2011). A major consequence of 
this is that restoration of collagen VI deposition by fibroblasts is expected to have a 
beneficial and strong impact, as demonstrated by a recent study from our laboratory 
showing that in situ grafting with wild type fibroblasts leads to proper deposition of 
collagen VI in the endomysial matrix of Col6a1–/– mice, with beneficial effects on muscle 
homeostasis (Urciuolo et al., 2013)   
Although the studies and findings discussed above unmistakably point at fibroblasts 
as the primary cell type producing collagen VI, no study until now has ever investigated 
the consequences caused by collagen VI deficiency in fibroblasts themselves. Besides the 
obvious significance for increasing our understanding on the roles exerted by collagen VI 
in different cells, such study would also have important implications for the diagnosis and 
therapy of human collagen VI-related diseases. Indeed, it is well know that fibroblasts and 
connective tissue actively cooperate with muscle and other tissues to maintain 
physiological properties and activities (Turrina et al., 2013; Murphy et al., 2011). 
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Therefore, during my PhD I performed several studies with fibroblasts derived from wild 
type and Col6a1–/– mice, aimed at throwing light on the intrinsic consequences on 
fibroblast survival and homeostasis elicited by collagen VI deficiency. My working 
hypothesis was that fibroblast damage due to collagen VI ablation may contribute and 
sustain the muscular defects that arise in vivo; and that collagen VI protein may exhibit 
distinctive autophagy instructive properties per se in fibroblasts. The study of fibroblasts 
in vivo is complicated, given the intricate interactions this cell type establishes in the 
different tissues. Therefore, I decided to set up an appropriate in vitro model for 
investigating various aspects of fibroblast biology in the presence or absence of collagen 
VI. First of all, I derived primary mouse embryonic fibroblast (MEF) cultures from wild 
type and Col6a1–/– mice, and immortalized them by transfection with a plasmid 
expressing the SV40 large T antigen. This allowed me to establish a stable in vitro 
fibroblast model to study collagen VI functions. Then, I demonstrated that these MEFs 
lines produced and secreted a proper ECM. Immunostaining and biochemical analyses 
showed that wild type MEFs secrete and deposit collagen VI. Moreover, collagen VI was 
tightly interconnected with fibronectin fibrils in the ECM and its secretion was increased 
by ascorbic acid treatment. As expected, Col6a1–/– MEFs were unable to assemble and 
secrete collagen VI but they were capable to produce fibronectin, collagen I and other ECM 
proteins, that also create a meshwork in the extracellular space. Once I established that 
this in vitro model is appropriate competent for ECM production, I investigated the 
cellular molecular and consequences caused by ablation of collagen VI in fibroblasts. In 
particular, I investigated whether lack of collagen VI has any impact on MEF survival 
processes, such as autophagy and apoptosis, as previously found in skeletal myofibers. 
Moreover, I performed studies aimed at dissecting the molecular pathway linked to 
Col6a1–/– defects in MEFs. 
Considering the previous finding of autophagy deregulation in myofibers of Col6a1–/– 
mice (Grumati et al., 2010), I investigated the involvement of collagen VI in the regulation 
of autophagy in MEFs. I first analyzed protein extracts from wild type and Col6a1–/– MEFs 
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to assess their ability to undergo autophagy in basal conditions and after serum 
deprivation. Under serum withdrawal, Col6a1–/– MEFs displayed less LC3 lipidation than 
the WT MEFs, as indicated by decreased LC3-II/LC3-I ratio. Based on this evidence, I 
investigated the autophagic flux by taking advance of chloroquine, an autophagy inhibitor 
drug that blocks autophagosome-lysosome fusion (Klionsky et al., 2012). Col6a1–/– MEFs 
showed markedly increased accumulation of LC3 protein, both in the -I and -II forms, 
without any significant increase of the LC3-II/LC3-I ratio. In parallel, I monitored 
autophagosome formation using stable wild type and Col6a1–/– MEF lines expressing a 
GFP-LC3 reporter. Analysis of fluorescent puncta analyses revealed massive formation of 
LC3-positive autophagosomes in Col6a1–/– MEFs, without any significant increase 
following serum starvation stimuli, which was instead detectable in wild type MEFs. These 
findings revealed an accumulation of autophagosomes in Col6a1–/– fibroblasts, likely due 
to impaired autophagic flux rather than to increased autophagosome formation rate.  
 Analysis for p62, a selective autophagy substrate that also binds LC3 (Bjørkøy et al., 
2006), showed decreased p62 protein levels in Col6a1–/– MEFs, independently of serum 
starvation. Of note, p62 transcript levels were also decreased in Col6a1–/– MEFs both in 
basal condition and after serum starvation, thus explaining the decreased p62 protein 
levels in Col6a1–/– MEFs and preventing the monitoring of p62 as marker of protein 
consumption in these cells. In the experimental conditions applied here, analysis of p62 
did not allow revealing any information about protein consumption due to the lack of p62 
protein degradation after serum depletion in both wild type and Col6a1–/– MEFs. It was 
reported that p62 synthesis can change at the transcriptional level due to several factors, 
and p62 expression is upregulated during prolonged starvation (Mizushima and 
Yoshimori, 2007; Ichimura et al., 2008; Jiang and Mizushima, 2014). Therefore, it will 
interesting to evaluate p62 turnover in wild type and Col6a1–/– MEFs after a shorter 
starvation time.  Nonetheless, the present data suggest that p62 activity is altered in 
Col6a1–/– fibroblasts, due to the decreased expression at the translational level. Literature 
work indicate that a decline in p62 content and expression, which is related to a decrease 
of proteasome activity and of selective autophagic removal, may contribute to the 
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accumulation of insoluble polyubiquitinated protein aggregates and to the deregulation of 
the activity of the standard autophagic pathway as well as of other non-canonical 
pathways (Komatsu et al., 2007; Wooten et al., 2008; Kim et al., 2014). Therefore, p62 
deregulation in Col6a1–/– MEFs may contribute to a defective cellular state regarding 
autophagy. Moreover, decreased p62 mRNA translation may be linked to reduced 
phosphorylation of the extracellular signal-regulated kinases 1 and 2 (Erk1/2) (Kim et al., 
2014; Lee et al., 2010), and/or to aberrant activation of TFEB translational program 
(Settembre et al., 2011), as indeed displayed by Col6a1–/– MEFs. 
To understand the signaling defects involved in the deregulated autophagy of Col6a1–
/– MEFs, I analyzed the activation status of different protein kinases acting on autophagy. 
These studies allowed me to reveal that AMPK is hyperactivated in Col6a1–/– MEFs, and 
even more when cells are serum starved for 3 hr. As AMPK is a key metabolic energy 
sensor (Russell et al., 2014), its markedly increased phosphorylation point at a strong 
energy impairment in Col6a1–/– MEFs, as we previously demonstrated in myofibers 
(Grumati et al., 2010), which is worsened by autophagy induction stimuli. AMPK 
activation is also implicated in autophagy activation, via mTORC1 inhibition and Ulk1 
phosphorylation at different serine residues (Egan et al., 2010; Russell et al., 2014). We 
therefore analyzed Ulk1 phosphorylation at Ser 555 and Ser 757, in order to assess its 
concurrent and opposite regulation by AMPK (acting positively) and mTORC1 (acting 
negatively) (Egan et al., 2010; Kim et al., 2011; Shang and Wang, 2011). Interestingly, and 
at difference from wild type MEFs, in Col6a1–/– MEFs we did not detected any decrease in 
Ulk1 phosphorylation at Ser 555 after serum starvation, which is fully consistent with the 
over-activation of AMPK. In Col6a1–/– MEFs, under serum starved conditions we also 
detected a slightly increased activity of Akt, a serine threonine kinase that plays central 
role in the regulation of a wide range of cell survival mechanisms. Increased Akt activation 
led us to speculate about a compensatory mechanism to assure cell survival of Col6a1–/– 
MEFs in the stressed condition (see also below discussion on apoptosis). Furthermore, 
Akt negatively regulates autophagy induction in mammalian cells, by acting on mTORC1 
 
 
37 
 
Discussion Part I 
signaling (Manning and Cantley, 2007). In agreement with this, we found increased 
activation of mTORC1 in Col6a1–/– MEFs concurrently to autophagy induction stimuli, by 
means of enhanced phosphorylation of the downstream targets S6 and 4E-BP1. It is 
reasonable to speculate that mTORC1 is influenced by the abnormal Akt activation in 
Col6a1–/– MEFs. Indeed, mTORC1 activity further determined an increase in the inhibitory 
Ser 757 phosphorylation of Ulk1, which it is known to antagonize the interaction between 
Ulk1 and AMPK (Kim et al., 2011; Shang and Wang, 2011). Although AMPK over-activation 
was expected to lead to premature autophagy induction in Col6a1–/– MEFs, both the 
initiation and maturation steps of autophagy were blocked by the concurrent activity of 
mTORC1, leading to autophagosome accumulation.  
The inability to degrade autophagic vacuoles (a so called "off-rate" block) can be due 
to impaired capability for lysosomal degradation (Huynh et al., 2007; Shen and 
Mizushima, 2014). Thus, I decided to investigate also the late stage of the autophagic 
process, evaluating lysosome contribution to the degradation of autophagosomes. 
Interestingly, Col6a1–/– MEFs exhibited enlarged lysosomes when compared to wild type 
MEFs. This condition is similar to the pattern displayed by wild type MEFs following 
treatment with the lysosome inhibitor chloroquine, a drug known to lead to lysosome 
dilation (Yoon et al., 2010; Chen et al., 2011). The massive presence of enlarged lysosomes 
in Col6a1–/– MEFs was independent from serum starvation, and furthermore correlated 
with impaired autolysosome formation and LAMP-2 protein depletion in basal condition. 
On the other side, LAMP-2 protein content was maintained after serum starvation, and 
LAMP-2 mRNA levels were unchanged in Col6a1–/– MEF. Thus, LAMP-2 was altered in 
Col6a1–/– MEFs only in basal condition, but this basal depletion was sufficient to block the 
proper fusion of autophagosomes with lysosomes, as confirmed by co-immunostaining for 
autophagosome and lysosome markers. Interestingly, literature studies showed that 
LAMP-2 depletion inhibits the autophagosome-lysosome fusion, thus causing a “traffic 
jam” that culminates in the accumulation of autophagosomes (Huynh et al., 2007; Tanaka 
et al., 2000). LAMP-1 and LAMP-2 are indeed required for proper autolysosome formation 
and hence for the removal of autophagosomes (González-Polo et al., 2005; Huynh et al., 
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2007; Fortunato et al., 2009; Shen and Mizushima, 2014). As González-Polo and colleagues 
showed, LAMP-2 depletion in HeLa cells and MEFs correlates with starvation-induced cell 
death, with features of accumulation of autophagosomes and of apoptotic signaling 
activation (González-Polo et al., 2005). On the other side, it is also known that during 
autophagy lysosomal function is regulated by the fusion of autophagosomes with 
lysosomes and relies upon mTORC1 suppression (Zhou et al., 2013). Thus, the alteration 
of lysosome morphology and structure in Col6a1–/– MEFs is also linked with the sustained 
mTORC1 activity and the decreased autolysosome formation. Taken together, these 
results point at a failure to maintaining a proper off-rate of autophagy in Col6a1–/– MEFs, 
sustained both by lysosomal and mTORC1 contribution.  
Given the striking lysosome defects in Col6a1–/– MEFs , I decided to examine the 
involvement of TFEB, a transcription factor that has been shown to have a master 
regulatory role in lysosome biogenesis and autophagy activity (Sardiello et al., 2009; 
Settembre et al., 2011). Towards this aim, I transfected wild type and Col6a1–/– MEFs with 
a GFP-TFEB expressing plasmid in order to analyze TFEB localization under basal 
conditions and after serum starvation. At difference from wild type MEFs, where GFP-
TFEB relocalized from cytoplasm to nucleus after serum withdrawal as expected 
(Settembre et al., 2012), Col6a1–/– MEFs exhibited a peculiar GFP-TFEB localization 
pattern in response to serum starvation. First of all, GFP-TFEB was largely localized in the 
nucleus already in basal conditions. Moreover, GFP-TFEB was not able to respond to 
starvation with the proper activation, and relocated to the cytoplasm when serum was 
depleted. Thus, we can argue that the translational program activated by TFEB was 
altered due to collagen VI ablation. Transcription of LC3 and p62 genes, two major targets 
of TFEB, was indeed abnormally regulated in Col6a1–/– MEFs after serum depletion, and 
LC3 in particular did not respond to serum withdrawal. We are currently investigating the 
transcriptional activity of other Atg genes known to be regulated by TFEB, as well as of 
endogenous TFEB. Interestingly, knockdown of Erk1/2 is known to induce nuclear 
translocation of TFEB to a similar extent as serum starvation (Settembre et al., 2011). Erk 
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plays an important role in the maturation step of autophagy and in lysosome stabilization 
(Corcelle et al., 2007; Duan et al., 2014), and its inhibition can result in autophagic 
impairments, and eventually in cell death (Duan et al., 2014). Of note, I found that Erk1/2 
activation is compromised in Col6a1–/– fibroblasts. Thus it is reasonable to argue that 
Erk1/2 deregulation in Col6a1–/– fibroblasts may account for a premature nuclear 
translocation of the transcription factor TFEB and for lysosomal destabilization. The 
presence of a lysosomal stress in Col6a1–/– MEFs also contributes in this direction, despite 
the slight residual activity of mTOR should act in reverse towards TFEB translocation 
under serum starved conditions.  
To further evaluate the role of collagen VI in autophagy regulation, I carried out 
biochemical analysis of LC3 lipidation in wild type and Col6a1–/– MEFs grown onto 
different ECM proteins, provided as adhesion substrates. In this context, my major aim 
was to evaluate the ability of collagen VI to regulate autophagy as adhesion substrate. 
Coating onto native collagen VI of wild type and Col6a1–/– MEFs showed a different 
pattern of LC3 lipidation: (i) in wild type MEFs, the LC3-II/LC3-I ratio was maintained, but 
LC3 was degraded to a bigger extent after serum depletion, suggesting an effect on 
autophagy induction; (ii) in Col6a1–/– MEFs, the LC3-II/LC3-I ratio was apparently 
unaffected, with only a small increase after serum depletion, but notably the total amount 
of LC3 protein was reduced. Thus, coating onto collagen VI reactivates LC3 degradation in 
Col6a1–/– MEFs. Adhesion onto collagen VI appeared to elicit also an effects on the 
autophagy initiation step, both in wild type and Col6a1–/– MEFs, showing a trend in 
restoring Ulk1 phosphorylation levels at the inhibitory site Ser 757. These findings 
highlight the ability of collagen VI to modulate autophagy, when in contact with 
fibrbolasts adhering on it. An increasing number of emerging in vitro studies demonstrate 
that ECM components are able to modulate autophagy in different manners (Tuloup-
Minguez et al., 2011; Neill et al., 2014). Here, we show that collagen VI is an ECM protein 
exhibiting instructive properties towards autophagy regulation. We are currently 
investigating the role of collagen VI coating in the regulation of mTORC1 activity. In 
Col6a1–/– MEFs, in particular, I am evaluating whether collagen VI coating is able to rescue 
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mTOR residual inhibitory activity under autophagy induction. In addition, I am 
investigating whether collagen VI coating is capable to rescue the lysosomal defects of 
Col6a1–/– MEFs. 
All the results concerning the autophagy deregulation displayed by Col6a1–/– MEFs 
converge to the concept of an altered basal condition due to the lack of extracellular 
collagen VI. Of note, the proper baseline regulation of autophagy is essential for cellular 
homeostasis, differentiation, development and survival (Mizushima and Komatsu, 2011). 
When nutrients or growth factors are scarce, collagen VI null fibroblasts, with altered 
basal rate of autophagy, are unable to readily respond to energy demands with the 
canonical catabolic and survival pathways. I speculate that in resting condition mTORC1 
and TFEB deregulation affects lysosomal integrity and autophagy maturation steps (Shen 
and Mizushima, 2014). On the other side, it can be also inferred that AMPK over-
activation, due to energy demand in Col6a1–/– MEFs, push the cell towards autophagy. 
Under stress conditions, indeed, the degradation of intracellular material through 
autophagy becomes an alternative source of energy (Kroemer et al., 2010). Thus, Col6a1–/– 
fibroblasts try to ensure protein turnover and survival by generating a lot of 
autophagosomes that finally accumulate, exacerbating cell status. In parallel, Col6a1–/– 
MEFs exhibit reduced Erk1/2 activation, that relates with altered TFEB localization and 
activity (Settembre et al., 2011). This leads to aberrant regulation of LC3 and p62 gene 
transcription during starvation, further impinging on cellular capacity for autophagy (Kim 
et al., 2014; Settembre et al., 2011).  
Two other remarkable features I found affected in Col6a1–/– fibroblasts model are 
apoptosis and mitochondrial network. In past studies, we demonstrated that the presence 
of mitochondrial dysfunctions and spontaneous apoptosis in skeletal muscles of Col6a1–/– 
mice and UCMD/BM patients (Irwin et al., 2003; Angelin et al., 2007; Sabatelli et al., 2012). 
I analyzed apoptosis in MEFs, using different experimental approaches as TUNEL and flow 
cytometric assays. I found that apoptosis occurrence was more than doubled in Col6a1–/– 
MEFs, with respect to wild type fibroblasts in the same culturing condition. In agreement 
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with the altered autophagic response to starvation, the rate of cell death in Col6a1–/– MEFs 
was further increased by serum depletion. In fact, a hallmark of cells defective for 
autophagy is an increased susceptibility to apoptotic stimuli, which normally would 
activate autophagy to promote cell survival (Levine and Kroemer, 2008; Fimia and 
Piacentini, 2010). Annexin V and propidium iodide stainings demonstrated that not only 
apoptosis is increased in Col6a1–/– MEFs, but that also final stages of late apoptosis and 
necrosis-like events are increased, indicating that collagen VI null fibroblasts are more 
sensitive to stress-induced cell death. Importantly, collagen VI was able to rescue the 
apoptotic phenotype and promote cell survival in Col6a1–/– MEFs, both basally and after 
serum starvation. On the contrary, coating with collagen I, used as a control, did not 
rescue apoptosis in Col6a1–/– MEFs, implying a specific effect elicited by collagen VI.  
Considering the massive accumulation of autophagosomes in Col6a1–/– MEFs, the 
finding of a concomitant necrosis-like cell death prompted me to investigate whether 
some kind of autophagy-dependent cell death was occurring. In fact, it has beeen widely 
recognized that autophagic (or type II) cell death is associated with appearance of 
autophagosomes and membrane permeability to vital dyes (Wirawan et al., 2012; Shen 
and Codogno, 2011; Yu et al., 2004). If the altered autophagy regulation in Col6a1–/– MEFs 
contributed to cell death, one would expect that inhibition of autophagy leads to increased 
cell survival (Yu et al., 2004). On the contrary, we found that only a minor fraction of 
necrosis-like cell death appeared to decrease in Col6a1–/– MEFs when autophagy was 
inhibited by chloroquine or 3-MA treatments, whereas the major percentage of fibroblasts 
were dying via apoptosis in a 3-MA dose-dependent manner. These results allow to argue 
that autophagic contribution to cell death in collagen VI null fibroblasts was irrelevant. 
Instead, the markedly increased incidence of apoptosis in Col6a1–/– MEFs was linked to 
increased activation of caspase 9 and caspase 3. Indeed, we found that these caspases 
were prematurely cleaved in Col6a1–/– MEFs in basal condition, and also to a major extent 
when serum was depleted. As expected, in wild type MEFs, caspase activation was only 
detected under apoptosis inducing stimuli, such as serum starvation or staurosporine 
treatment (González-Polo et al., 2005; Zanotti et al., 2011). Cleavage of caspase 9 implied 
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the activation of the intrinsic apoptotic pathway, linking the cell death found in Col6a1–/– 
MEFs to intracellular stress signals, such as mitochondrial damage (Shalini et al., 2014). 
Up to date, we did not estimate the activation of the extrinsic pathway, by means of 
caspase 8 activation assays, but it will be interesting to understand whether both 
pathways contribute to the autophagic defects of Col6a1–/– MEFs. In any case, caspase 
activation further excludes the possible involvement of autophagic cell death in this 
context (Galluzzi et al., 2015). Furthermore, adhesion onto collagen VI also exhibited a 
clear pro-survival effect in wild type fibroblasts. In fact, collagen VI coating ameliorated 
cell survival in wild type MEFs subjected to serum withdrawal, and this effect was not 
phenocopied by collagen I. This suggests a specific role of extracellular collagen VI on 
promoting cell survival and counteracting apopotosis. We postulate that native collagen 
VI exhibits distinct functions as cytoprotective factor for MEFs, in agreement with 
previously observations in avian corneal fibroblasts (Howell and Doane, 1998) and in 
fibroblasts protein extracts (Rühl et al., 1999). 
Mitochondria play an important role in cell homeostasis, given their key role in  
metabolism and adaptation to nutrient/growth factor stress (Scorrano, 2005; Liesa and 
Shirihai, 2013). Moreover, fusion and fission dynamics of mitochondrial network directly 
influence not only mitochondrial metabolism, but also cell death, autophagy, and a large 
number of signaling pathways (Kasahara and Scorrano, 2014). Thinking at mitochondrial 
dysfunction as a causative effect for apoptosis induction in Col6a1–/– MEFs, we analyzed 
mitochondrial network morphology, using different probes and markers. Interestingly, we 
found that Col6a1–/– MEFs displayed a fragmented mitochondrial network when 
compared to wild type cells, which exhibited tubular elongated mitochondria in the 70% 
of the cases. Defective mitochondrial elongation is often associated to mitochondrial 
dysfunctions, which dissipate cellular ATP and prime cell toward apoptosis (Scorrano, 
2005; Gomes and Scorrano, 2011). Indeed, unbalanced rate of mitochondrial fusion and 
fission can have important effects on cell bioenergetics, because of the accumulation of 
irreversibly damaged mitochondria (Twig et al., 2008; Liesa and Shirihai, 2013). These 
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dynamics, in concert with autophagy, are crucial for mitochondrial quality control 
mechanisms and cell survival (Liesa and Shirihai, 2013; Kasahara and Scorrano, 2014). 
Serum starvation induced a markedly increased rate of mitochondrial fragmentation in 
Col6a1–/– MEFs. In literature starvation is reported to cause elongation of mitochondria, 
by inhibiting Drp1 recruitment and mitochondria fission. Starvation-induced elongation is 
functional to prevent mitochondria removal by autophagy and to allow cell survival in 
starving cells (Gomes and Scorrano, 2011; Liesa and Shirihai, 2013). During starvation, 
mitochondria unable to elongate are latently dysfunctional and waste cellular ATP to 
sustain their membrane potential (Gomes and Scorrano, 2011). Therefore, sustained 
fission of mitochondria in Col6a1–/– MEFs was presumably linked to loss of mitochondria 
functionality and/or to aberrant mitochondria autophagic removal (mitophagy) during 
limited nutrient availability. Different signals are required to initiate the removal of 
damaged mitochondria. Loss of mitochondrial membrane potential and prior 
mitochondrial fragmentation represent major signals for mitophagy (Twig et al., 2008; 
Gomes and Scorrano, 2008), as well as translocation of the PARK2-associated ubiquitin 
ligase, Parkin, from the cytosol to the mitochondrion (Narendra et al., 2008; Youle and 
Narendra, 2011). To evaluated mitophagy involvement and functionality in Col6a1–/– 
MEFs, I studied Parkin translocation, by transfecting cells with YFP-Parkin (Narendra et 
al., 2008). I found that in basal conditions YFP-Parkin was recruited more frequently to 
mitochondria in Col6a1–/– MEFs, suggesting a latent dysfunction of mitochondria, which 
activated massive Parkin recruitment and selective mitophagy. Mitochondrial removal, 
evaluated after both serum starvation and use of the mitochondrial uncoupler CCCP, is 
still under investigation. Up to date, the preliminary data obtained led us to speculate that, 
although Parkin recruitment should prime mitophagy in Col6a1–/– MEFs, the cell 
machinery was not able to activate a proper clearance of altered mitochondria, thus losing 
the capacity to restore mitochondria metabolism upon damage and to limit apoptosis 
activation. Further studies are required to strengthen this hypothesis. In addition, it will 
be important to determine mitochondria functionality in Col6a1–/– MEFs. 
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In conclusion, the data I collected in this PhD thesis work highlight a role for the ECM 
protein collagen VI as a factor able to modulate cell survival pathways in multiple ways. 
Indeed addition of collagen VI, used as a substrate for fibroblast adhesion, modulates 
autophagy and improves cell survival in serum withdrawal condition. Furthermore, 
genetic ablation of collagen VI in our fibroblast model impinges both on the initiation and 
the completion of the autophagy flux, leads to remodeling of mitochondrial shape, and 
causes apoptosis. Previous results I obtained in the first year of my PhD demonstrated 
that similar alterations in apoptosis and autophagy are present also in primary fibroblasts 
derived from diaphragms of Col6a1–/– mice (data not shown). The complex interplay 
between apoptosis and autophagy is critical to the overall fate of the cell (Mariño et al., 
2014; Booth et al., 2014). Therefore, the remarkable alterations of both autophagy and 
apoptosis in Col6a1–/– fibroblasts indicate that this cell type likely plays a major role in the 
pathophysiological defects of collagen VI diseases and in the onset and progression of the 
muscle pathology of Col6a1–/– mice and of UCMD/BM patients, as previously postulated 
but never demonstrated (Zou et al., 2008; Allamand et al., 2011; Sabatelli et al., 2012). 
Interstitial fibroblasts that are present in muscle tissue both during and after myogenesis 
not only play pivotal roles in muscle development but also protect myoblasts from 
apoptosis (Zhang et al., 2010). Thus, a genetically inherited muscle defect, as in the case of 
collagen VI mutations, may lead to complex and additional pathological effects through 
the integration of fibroblast and myoblast related defects.              
Although the involvement of collagen VI in apoptosis and autophagy is well 
documented, the molecular mechanisms involved in the intracellular transduction of the 
extracellular signals elicited by collagen VI are still unknown. In particular, it remains to 
be established whether and which transmembrane receptor is involved, or whether 
collagen VI mostly acts by regulating the biomechanical properties and fine-tuning the 
ECM three-dimensional organization. Recent independent work from our laboratory 
suggests that this ECM molecule has both biomechanical (stiffness) and biochemical 
(signaling) roles in the different tissues (Urciuolo et al., 2013; Alexopoulos et al., 2009). 
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Although future work is needed to understand in detail the intricate aspects of collagen VI 
biology and functions in skeletal muscles and in other tissues, the results of the present 
study provide further insight into the dynamic nature of the ECM and in particular of one 
of its major constituents. Collagen VI produced by fibroblasts in the muscle-associated 
connective tissues may serve as an ECM factor that allows for rapid reconstitution of 
skeletal muscle after different stress, and its deficiency is likely crucial for the appearance 
of the muscle pathology in mice and in patients. 
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Figure 1. Characterization of extracellular matrix (ECM) protein 
production by wild type and collagen VI null (Col6a1–/–) MEF lines. (A) 
Immunofluorescence of collagen VI (red) and fibronectin (green) deposition 
in the ECM of WT and Col6a1–/– MEF lines. Nuclei were stained in blue with 
Hoechst 33258. Scale bar, 25 µm. (B) Western blot analysis of collagen VI α1 
and α3 chain (α1(VI), α3(VI)) production in culture media and cell extracts 
from WT and Col6a1–/– MEFs. Where indicated 0.25 mM ascorbic acid was 
used to induce collagen secretion. (C) qRT-PCR analyses of Col6a1, Col6a2 and 
Col6a3 mRNA in WT and Col6a1–/– MEF lines. WT, wild type. **, P < 0.01; ***, P 
< 0.001. 
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Figure 2. Autophagy off-rate flux is blocked in Col6a1–/– MEFs. (A, B) 
Western blot analysis of total cell extracts from WT and Col6a1–/– MEFs in 
basal medium (Serum+, S+) and after serum withdrawal (Serum-, S-) for 3 hr. 
(A) LC3, p62 and Atg5-12 protein levels after serum starvation. (B) 
Monitoring of the autophagy flux through Western blot analysis of LC3 
lipidation after 50 µM chloroquine (CQ) treatment. (C) Quantification of the 
relative intensity of LC3-II/LC3-I ratio showed in D (mean data of at least 
three independent biological samples). (D, E) Detection of LC3-II puncta in 
WT and Col6a1–/– MEFs from GFP-LC3 reporter mice. LC3 puncta 
(autophagosomes) accumulate in Col6a1–/– MEFs both in Serum+ and in 
Serum- condition. Scale bar, 25 µm. Corresponding quantification of GFP-LC3 
puncta per cell area is shown in E. (F) qRT-PCR analysis of LC3B and p62 
mRNA expression. *, P < 0.05, **, P < 0.01, ***, P < 0.001; #, P < 0.01, Col6a1–/–  
versus WT MEFs . WT, wild type.  
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Figure 3. AMP-activated protein kinase (AMPK) is hyperactivated in 
Col6a1–/– MEFs, but persistent mTOR signaling is present. (A-C) Western 
blot analyses of total cell extracts from WT and Col6a1–/– MEFs in basal medium 
(S+) and after serum withdrawal (S-) for 3 hr. WT, wild type. (A) AMPK 
activation and its phosphorylation activity on Ulk1 at Ser 555. (B) Akt and 
Erk1/2 activation by phosphorylation. (C) mTOR downstream target analyses 
(4E-BP1 and S6) and its phosphorylation activity on Ulk1 at Ser 757. WT, wild 
type.  
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Figure 4. Autophagy modulation by collagen VI as adhesion substrate. 
(A) Western blot analyses of total cell extracts from WT and Col6a1–/– MEFs in 
basal medium (S+) and after serum withdrawal (S-) for 3 hr. When indicated, 
cells were grown onto collagen VI (Col VI) as adhesion substrate. (B-D) 
Densitometric quantifications of relative intensity of two independent blotting 
experiments as in A. Quantification of LC3-II/LC3-I ratio (B) and of p-Ulk1 
(Ser 757) on Ulk1 total protein (D) are showed. (C) Serum-induced 
conversion rate of LC3. WT, wild type. *, P < 0.05, **, P < 0.01. 
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Figure 5. Col6a1–/– MEFs showed enlarged lysosomes and decreased 
autolysosome formation. (A) Immunofluorescence of LAMP-2 lysosome 
marker showing normal lysosomes in WT cells and enlarged lysosomes in 
Col6a1–/– MEFs. The inserts show a magnification of boxed area. (B) 
Quantification of cells containing at least two enlarged lysosomes. Data 
represent mean percentages ± s.e.m. of cells with enlarged lysosomes of thirty 
images per condition. (C) Western blot analysis of LAMP-2 in WT and Col6a1–
/– MEFs, in basal medium (S+) and after serum withdrawal (S-) for 3 hr. (D) 
Quantification of the relative intensity of LAMP-2/actin of three independent 
immunoblottings, as in C. (E) qRT-PCR analysis of LAMP-2 mRNA expression. 
(F) Coimmunostaining of LAMP-2 and LC3 on MEFs, after 3h of serum 
withdrawal. The right panels show the boxed areas of relative merged image. 
Col6a1–/– cells showed impaired autophagosome (green puncta) fusion to 
lysosomes (red) (arrowheads). Scale bars, 25 µm. (G) Schematic 
representation of the failure of autophagosome-lysosome fusion in Col6a1–/– 
MEFs (green star: autophagosome labeled by LC3; red star: lysosome labeled 
by LAMP2; orange star: autolysosome with merged LAMP2 and LC3 labeling).  
(H) Colocalization rate of LC3 and LAMP-2 staining. Mean percentages ± s.e.m. 
were calculated for at least fifteen images per condition. Serum+, basal 
medium; Serum-, 3 hr of serum withdrawal. Scale bar, 25 µm. WT, wild type. *, 
P < 0.05;  **, P < 0.01, ***, P < 0.001. 
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Figure 6. GFP-TFEB nuclear translocation analysis in wild type and 
Col6a1–/– MEFs. (A) Representative micrographs  of GFP-TFEB expressing 
MEFs in basal medium (Serum+) and after serum withdrawal (Serum-) for 3 
hr, following plasmid transfection (GFP-TFEB). Nuclei were stained in blue 
with Hoechst. (B) Quantification of WT and Col6a1–/– cells showing cytosolic 
or nuclear-translocated GFP-TFEB, as showed in A. Mean data are 
representative of at least three independent biological samples. WT, wild type 
*, P<0.05; **, P<0.001; ***, P<0.0001.  
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Figure 7. Apoptosis is increased in Col6a1–/– MEFs and collagen VI 
addition rescued the phenotype. (A) TUNEL assay. Left panel: 
representative micrographs; nuclei were stained in blue with Hoechst, TUNEL 
positive nuclei were in green. Right panel: quantification (n = 3) of TUNEL 
positive nuclei in WT and Col6a1–/– MEFs cultured on plastic wells (/), 
collagen VI (Col VI) or collagen I (Col I) proteins. (B-D) Annexin V/ PI 
(propidium iodide) flow cytometric analysis of WT and Col6a1–/– MEFs 
cultured for two days on plastic, collagen VI (Col VI) or collagen I (Col I) and 
serum depleted for the final 3 hr, where indicated. Data indicate the average 
for 10,000 cells collected in at least three independent biological samples. (B) 
Cell survival quantification. (C) Left panel: representative dot plots of flow 
cytometric analysis of annexin V/ PI for WT and Col6a1–/– MEFs. Right panel: 
quantification of annexin V (apoptotic) and PI positive (necrotic) cells. (D) 
Western blotting analysis of total cell extracts from WT and Col6a1–/– MEFs in 
complete DMEM with 10% serum, or without serum for the specified time (3 
hr, 6 hr). Cells were treated with 1 µM staurosporine, where indicated. WT, 
wild type. *, P < 0.05, **, P < 0.01, ***, P < 0.001. 
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Figure 8. Mitochondrial network is more fragmented and mitophagy is 
impaired in Col6a1–/– MEFs.  (A) Representative micrograph of MitoTracker 
labeled mitochondria of WT and Col6a1–/– MEFs. (B) Quantification of cells 
showing tubular or fragmented mitochondria network in WT and Col6a1–/– 
MEFs, following transfection with mitochondrial fluorescent plasmids 
(pMitoRed or Mito-YFP). ***, P<0.001. Mean data are representative of at least 
five independent biological samples. (C, D) Coimmunostaining of LAMP-2 and 
Tom20 on GFP-LC3 MEFs, after 3 hr of serum withdrawal. (D) Image 
magnification of the boxed areas showed in C. Differential merged staining are 
showed. Scale bars, 25 µm. (E) Co-transfection of  YFP-Parkin and pMitoRed 
plasmids in WT and Col6a1–/– MEFs. Arrows pointed to YFP-Parkin relocalized 
to mitochondria. (F) Left panel: representative micrograph of YFP-Parkin 
transfected Col6a1–/– MEFs. Arrows pointed to mitochondria-translocated 
YFP-Parkin. Right panel: quantification of cells showing YFP-Parkin 
translocation, as showed in the left panel, in WT and Col6a1–/– MEFs. (G) 
Immunostaining of Tom20 (showing mitochondria) in WT and Col6a1–/– 
MEFs, after 20 µM CCCP 24 hr treatment (or DMSO as a control). *, P < 0.05. 
WT, wild type.  
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Figure S1. Coimmunostaining of LC3 and collagen VI α3 chain (α 3(VI)), in 
WT and Col6a1–/– confluent MEFs. (A) Scale bar, 20 µm. (B) Magnification of the 
boxed area in A. Intracellular dots of α3(VI) are detected in Col6a1–/– MEFs, 
without any colocalization with autophagosomes. Scale bar, 10 µm. WT, wild 
type.  
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Figure S2. Chloroquine treatment induces lysosome enlargement in MEFs. 
WT and Col6a1–/– MEFs showing similar LAMP-2 immunostaining after 50 µM 
chloroquine treatment. Magnifications of the inserts show a detailed view of 
perinuclear swollen lysosomes. Scale bars, 25 and 5 µm. WT, wild type. 
Figures Part I        
63 
0 
1 
2 
wt 
TC 
wt 
NS 
3h 
ko 
TC 
ko 
NS 
3h 
0 
1 
2 
3 
wt 
TC 
wt 
NS 
3h 
ko 
TC 
ko 
NS 
3h 
+ - + - + - + - 
BNIP3 Becn1 
 m
R
N
A
 f
o
ld
 i
n
d
u
c
ti
o
n
 
(w
it
h
 r
e
s
p
e
c
t 
to
 W
T
 S
+
) 
 
WT 
Col6a1-/- 
Serum: 
Figure S4. Quantification of annexin V/ PI (propidium iodide) flow 
cytometric analysis of WT and Col6a1–/– MEFs cultured for two days and 
treated with 3-MA in basal medium (Serum+) or without serum (Serum-). 3-
MA increases apoptotis (annexin V+ cells) in a dose-dependent manner both 
in WT and Col6a1–/– MEFs. 3-MA autophagy inhibition is not sufficient to 
rescue cell death, indicating no contribution of autophagic cell death. WT, wild 
type. 
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Figure S3. qRT-PCR analysis of BNIP3 and Becn1 mRNA expression in WT 
and Col6a1–/– MEFs in complete media or after 3 hr of serum withdrawal. WT, 
wild type. 
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Table 1. Sequence of the qRT-PCR primers used. 
Forward primer (5’ > 3’)  Reverse primer (5’ > 3’)  
Col6a1 TGCCCTGTGGATCTATTCTTCG  CTGTCTCTCAGGTTGTCAATG  
Col6a2  CAACCGCATCATCAAGGTCA  GGGTCTCCCTGTCGTCCTTT  
Col6a3  AACCCTCCACATACTGCTAATTC  TCGTTGTCACTGGCTTCATT  
LC3  CACTGCTCTGTCTTGTGTAGGTTG  TCGTTGTGCCTTTATTAGTGCATC  
p62 
(Sqstm1) 
CCCAGTGTCTTGGCATTCTT  AGGGAAAGCAGAGGAAGCTC  
LAMP-2 CAAAAGGACAGTATTCTACAGCTCA CCACCGCTATGGGCACAA 
GAPDH  CACCATCTTCCAGGAGCGAG  CCTTCTCCATGGTGGTGAAGAC  
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Introduction Part II 
Part II: side projects 
 
1. Autophagy regulation in skeletal muscles 
Skeletal muscle is a tissue with a high intrinsic plasticity, able to readily respond to 
various stress conditions as contraction, physical exercise, nutritional changes, and aging. 
In order to display this plasticity and to maintain and preserve its high protein content, 
skeletal muscle needs a finely regulated catabolic system. Together with the ubiquitin-
proteasome system, autophagy is crucial to assure proper protein and organelle turnover 
and assure muscle homeostasis (Bonaldo and Sandri, 2013; Vainshtein et al., 2014).  
Autophagy is constitutively active in skeletal muscle, and failure to maintain a proper 
autophagic flux can lead to muscle pathology. For example, different atrophic conditions 
as well as laminin α2 deficiency are associated with excessive autophagy (Carmignac et al., 
2011; Mammucari et al., 2007; Masiero et al., 2009). Conversely, inefficient autophagy 
allows the accumulation of unfolded proteins, macromolecular aggregates and 
dysfunctional organelles, as demonstrated in mouse modes for several inherited muscle 
diseases, such as collagen VI-related myopathies and Duchenne muscular dystrophy 
(Grumati et al., 2010; De Palma et al., 2012; Spitali et al., 2013).  
Forkhead box class O family member proteins (FoxOs) are highly conserved 
transcription factors exerting a key role in muscle energy homeostasis (Schiaffino et al., 
2013). In nutrient-rich conditions, Akt pathway inactivates FoxO factors by 
phosphorylation. When energy is required, autophagy initiation requires both the 
suppression of protein synthesis via inactivation of Akt/mTOR axis and the concurrent 
activation of FoxO3. Active FoxO3 translocates to the nucleus and induces the 
transcription of several autophagic genes, such as LC3, Bnip3, Vps34 and Beclin 1 
(Mammuccari et al., 2007). Atg5 and Atg7 are also necessary to sustain skeletal muscle 
autophagy flux and maintain myofiber integrity (Raben et al., 2008; Masiero et al., 2009).  
Skeletal muscle is able to modulate its autophagic response in different physiological 
or stress conditions, such as contraction, fasting, mass wasting and metabolic 
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requirements, according to amino acids availability and energy consumption. This 
regulation occurs mainly through Akt/mTOR and AMPK axes, with different downstream 
cascades and pathway connections (Masiero et al., 2009; Vainshtein et al., 2014). 
Several human myopathies display defects of the autophagy-lysosome system, 
indicating the critical role of this catabolic pathway for muscle homeostasis (Sandri et al., 
2013).  Autophagic vacuolar myopathies (AVM), such as Danon and Pompe disease, are 
caused by mutation in non-Atg genes linked to lysosome or autophagolysosome functions. 
In these AVM diseases, autophagosomes accumulate inside myofibers due to their 
defective degradation, leading to myofiber degeneration and muscle weakness (Malicdan 
and Nishino, 2012). Recently, Vici syndrome, a multisystemic disorder also affecting 
skeletal muscles, was demonstrated to be caused by mutation of an autophagic gene called 
EPG5. Patients affected by Vici syndrome display lysosome-like vacuoles and p62 
accumulation in muscles, associated with a block of the autophagosome-lysosome fusion 
process (Cullup et al., 2013). 
A detailed molecular understanding of the autophagy processes in skeletal muscles is 
fundamental for elucidating its role under physiological and pathological conditions and 
for uncovering new targets for therapy. The development of treatments and drugs able to 
restore proper autophagy in pathological contexts will be of outstanding interest to design 
new therapeutic approaches for human diseases. 
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1.1. AMBRA1 regulation of skeletal muscle development 
Ambra1 is a key autophagy regulator and Beclin 1 interactor, with crucial role for 
embryogenesis and neural development in mammals (Fimia et al., 2007; Mizushima et al., 
2010). Ambra1 inactivation in mice by gene trap mutagenesis led to embryonic lethality. 
The E10-E14.5 homozygous Ambra1 gene trap (Ambra1gt/gt) mutant mouse embryos 
displayed a defective neural tube development, showing exencephaly and/or spina bifida. 
These defects were associated with excessive apoptosis, hyperproliferation and 
accumulation of ubiquitinated proteins in the nervous system, and to autophagy 
impairment in the developing embryo (Fimia et al., 2007).  
In basal conditions, Ambra1 tethers the Beclin 1/Vps34 complex to the microtubules, 
by directly binding the dynein motor complex (Di Bartolomeo et al., 2010). Upon 
autophagy induction Ulk1 phosphorylates and unlocks Ambra1 from the cytoskeleton, 
allowing Beclin 1/Vps34 complex to translocate at the ER and to initiate autophagosome 
formation (Di Bartolomeo et al., 2010). 
Moreover, Ambra1 has a role in determining Ulk1 stability and kinase activity (Nazio 
et al., 2013). In particular, mTOR phosphorylation inhibits Ambra1 activity in resting 
conditions; when autophagy is induced, Ambra1 is dephosphorylated and can interact 
with the E3-ligase TRAF6, to add Lys 63-linked ubiquitin chains to Ulk1, thus promoting 
its stabilization, self-association and function (Nazio et al., 2013). As described before, 
Ulk1 can in turn activate Ambra1 by phosphorylation, to sustain autophagy through a 
positive loop (Di Bartolomeo et al., 2010). 
Other results confirmed the involvement of Ambra1 in the embryonic and larval 
development of the zebrafish (Danio rerio) model (Benato et al., 2013). 
During the second year of my PhD, I participated to a large project aimed at 
elucidating the role of Ambra1 in skeletal muscle homeostasis and development. To 
investigate the role of Ambra1 in muscle development, this project first involved studies 
in zebrafish embryos via knockdown of Ambra1 paralogue genes as well as in Ambra1gt/gt 
mouse embryos. These studies allowed demonstrating that Ambra1 is required for the 
proper morphogenesis of skeletal muscle, and that its depletion cause striking structural 
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and functional alterations of muscles. My own contribution to the project consisted in the 
histological and light microscopy analysis of skeletal muscles of Ambra1gt/gt mouse 
embryos.   
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1.2. Autophagic impairment in a sarcopenic patient with rigid spine 
syndrome and FHL1 mutation 
Four-and-half LIM domain 1 (FHL1) is a protein highly expressed in skeletal and 
cardiac muscle (Brown et al., 1999; Morgan and Madgwick, 1999). FHL1 is shown to be 
involved in different regulatory pathways of the skeletal muscle, such as myogenesis and 
fiber size determination (Lee et al., 2012; Cowling et al., 2008). Mutations in the FHL1 
gene are associated with several muscle diseases, including X-linked myopathy with 
postural muscle atrophy (XMPMA), reducing body myophathy (RBM) and rigid spine 
syndrome (RSS) (MA) (Bertrand et al., 2014). 
In the last part of my PhD, I contributed to the characterization of the autophagic 
defects in a patient displaying sarcopenia and rigid spine syndrome and bearing a 
missense mutation in the FHL1 gene (p.C150R). Muscle biopsies from this patient showed 
FHL1-positive aggregates inside myofibers and near the myonuclei. To better evaluate the 
impact of these aggregates in the onset of the myopathy, I participated to the evaluation of 
the aggregates composition and to the biochemical analysis of autophagy markers in 
patients’ biopsies. This analysis revealed that ubiquitinated proteins and p62 were 
increased in patient muscles when compared to unaffected muscle controls. Beclin 1 and 
Bnip3 protein content was also increased, together with a slight induction in LC3 
lipidation. Interestingly, the aggregates detected in patient muscles contained nuclear 
fragmented material and were positive for p62 and LC3 staining, suggesting the 
involvement of an aggrephagy-like process in this pathological context.  
These results highlight the important contribution of a selective autophagy pathway 
in the pathogenesis of the myopathy linked to FHL1 p.C150R mutation. 
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